| Save 25% on a pre-paid one year subscription. |
|
|
 251 |
Filed: 6/24/2013, Entered: None |
 |
|
The parties filed documents under seal in this action. This matter has been resolved and the sealed documents are no longer required. It is hereby ORDERED that all sealed documents filed in this action be returned to counsel for the filing party, and counsel shall arrange with the clerk to retrieve all sealed documents w/in 20 days from the date of this Order. If counsel fails to comply, the clerk is DIRECTED to shred the sealed documents. Signed by District Judge Henry C. Morgan, Jr. on 6/24/13 and filed 6/24/13. (lbax, ) (Entered: 06/26/2013)
|
|
 Request |
 |
|
|
| -- |
Filed: 9/13/2005, Entered: 8/25/2006 |
Record(s) |
|
Case file sent to Federal Records Center. (tlev)
|
|
|
|
|
|
| -- |
Filed: 9/13/2005, Entered: 8/21/2006 |
Record(s) |
|
Case file sent to Federal Records Center. (tlev)
|
|
|
|
|
|
| -- |
Filed: 6/23/2004, Entered: 1/11/2005 |
Docket Annotation |
|
Per counsel - all are in agreement regarding costs - counsel will present an agreed order to Judge Morgan regarding costs. (ariv)
|
|
|
|
|
|
| 250 |
Filed: 1/12/2004, Entered: 1/13/2004 |
USCA Judgment |
|
JUDGMENT OF USCA affirming the judgment of the District Court (certified copy) Re: [229-1] appeal, filed. (jcow)
|
|
|
|
|
|
| 249 |
Filed: 1/12/2004, Entered: 1/13/2004 |
USCA Mandate |
|
Opinion of USCA re: [229-1] appeal by Smithkline Beecham, Glaxosmithkline PLC 11/21/03 (jcow)
|
|
|
|
|
|
| 248 |
Filed: 11/24/2003, Entered: 11/24/2003 |
USCA Mandate |
|
Advance copy of Opinion of USCA re: [229-1] appeal by Smithkline Beecham, Glaxosmithkline PLC, decided 11/21/03, affirming the decision of the District Court (jcow)
|
|
|
|
|
|
| 247 |
Filed: 8/20/2003, Entered: 8/21/2003 |
Transcript |
|
TRANSCRIPT for dates of 05/14/02 Motion to Seal Documents; Diane Gray, OCR (cdod)
|
|
|
|
|
|
| 246 |
Filed: 9/6/2002, Entered: 9/6/2002 |
Judgment* |
|
Amended JUDGMENT amending the judgment dated 05/23/02 to include: Counterplaintiffs' claims against Counterdefendants in this case are hereby dismissed as moot, without prejudice, and may be reinstated in the event the US Court of Appeals for the Federal Circuit reverses these consolidated cases or remands these consolidated cases to this Court for further consideration; entered by the Clerk 09/05/02 and filed 09/06/02; ob Copies Mailed: 09/06/02 [EOD DATE: 9/6/02] (cdod)
|
|
|
|
|
|
| 245 |
Filed: 9/5/2002, Entered: 9/6/2002 |
Order |
|
All Cases ORDER granting [241-1] motion by Smithkline Beecham, Glaxosmithkline PLC For Certification Pursuant To Fed.R.Civ.P.54(B) Of The Judgments Relating To The Cole Patents; The Court certifies for immediate appeal pursuant to Federal Rule of Civil Procedure 54(b) the Court's judgments that U.S. Patent Numbers 4,525,352, 4,529,720, 4,560,552, 6,031,093, 6,048,977, 6,051,703, and 6,218,380 are invalid for the reasons given and the Court's judgment denying GSK's motion to compel discovery and granting Geneva's motion for a protective order; and the judgment is amended; entered 09/04/02 and filed 09/05/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 09/06/02 [EOD Date: 9/6/02] (cdod)
|
|
|
|
|
|
| 244 |
Filed: 8/20/2002, Entered: 8/21/2002 |
Memorandum in Opposition |
|
MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in opposition to [243-1] Submission Of An Alternative Proposed Order Pursuant To Fed.R.Civ.P.54(B) by Geneva received (cdod)
|
|
|
|
|
|
| 243 |
Filed: 8/20/2002, Entered: 8/20/2002 |
Remark |
|
Geneva's Submission OF An Alternative Proposed Order Pursuant To Fed.R.Civ.P.54(b) For The Court's Consideration filed by plaintiff Geneva in response to [241-1] motion by Smithkline Beecham, Glaxosmithkline PLC For Certification Pursuant To Fed.R.Civ.P.54(B) Of The Judgments Relating To The Cole Patents (cdod)
|
|
|
|
|
|
| 242 |
Filed: 8/19/2002, Entered: 8/20/2002 |
Affidavit |
|
All Cases Declaration by Russell Sandidge [242-1] support memorandum by Smithkline Beecham, Glaxosmithkline PLC (cdod)
|
|
|
|
|
|
| 242 |
Filed: 8/19/2002, Entered: 8/20/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in support of [241-1] motion For Certification Pursuant To Fed.R.Civ.P.54(B) Of The Judgments Relating To The Cole Patents received (cdod)
|
|
|
|
|
|
| 241 |
Filed: 8/19/2002, Entered: 8/20/2002, Terminated: 9/5/2002 |
Motion for Miscellaneous Relief |
|
All Cases Emergency MOTION by Smithkline Beecham, Glaxosmithkline PLC For Certification Pursuant To Fed.R.Civ.P.54(B) Of The Judgments Relating To The Cole Patents with attached prposed order (not endorsed by all parties) (cdod) Modified on 08/20/2002
|
|
|
|
|
|
| 240 |
Filed: 7/19/2002, Entered: 7/23/2002 |
Order |
|
ORDER and OPINION invalidating Glaxosmithkline's patent protection for Cole '552, Cole '352, and Cole '720; entered and filed 7/19/02 (signed by Judge Henry C. Morgan Jr.) Copies Mailed: 7/23/02 [EOD Date: 7/23/02] (mwin)
|
|
|
|
|
|
| -- |
Filed: 7/19/2002, Entered: 7/23/2002 |
Permanent Record |
|
Permanent Record (mwin)
|
|
|
|
|
|
| -- |
Filed: 7/19/2002, Entered: 7/23/2002 |
Terminated Case |
|
Case closed (mwin)
|
|
|
|
|
|
| -- |
Filed: 7/19/2002, Entered: 7/23/2002 |
Docket Annotation |
|
Note: Judgment previously entered as directed 5/23/02 on ruling in open court (mwin)
|
|
|
|
|
|
| 239 |
Filed: 7/17/2002, Entered: 7/18/2002 |
Remark |
|
Letter re: no objections to amended Bill Of Costs filed by Teva by defendant Glaxosmithkline PLC, defendant Smithkline Beecham (cdod)
|
|
|
|
|
|
| 238 |
Filed: 7/17/2002, Entered: 7/18/2002 |
Bill of Costs |
|
All Cases Amended Bill of costs in the amount of 65451.44 by Teva Pharmaceuticals (cdod) Modified on 07/18/2002
|
|
|
|
|
|
| 237 |
Filed: 7/3/2002, Entered: 7/5/2002 |
Transcript |
|
TRANSCRIPT of hearing on motion 4/5/02 before Magistrate Judge Tommy E. Miller (mwin)
|
|
|
|
|
|
| 236 |
Filed: 6/25/2002, Entered: 6/26/2002 |
Bill of Costs |
|
ALL CASES: Bill of costs in the amount of $65,451.44 by Teva Pharmaceuticals (ariv)
|
|
|
|
|
|
| -- |
Filed: 6/17/2002, Entered: 6/17/2002, Terminated: 1/13/2004 |
USCA Case Number |
|
USCA Case Number Re: [229-1] appeal by Smithkline Beecham, Glaxosmithkline PLC USCA NUMBER: 02-1439 (jcow)
|
|
|
|
|
|
| 235 |
Filed: 6/12/2002, Entered: 6/13/2002 |
Bill of Costs |
|
Bill of costs in the amount of $21,212.78 by Geneva (ariv)
|
|
|
|
|
|
| 234 |
Filed: 6/11/2002, Entered: 6/11/2002 |
Order |
|
All Case ORDER granting [233-1] motion by Ranbaxy Laboratories, Ranbaxy, Teva Pharmaceuticals, Geneva to Extend Time To Bill Of Costs until June 25, 2002; agreed, entered and filed 06/11/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 06/11/02 [EOD Date: 6/11/02] (cdod)
|
|
|
|
|
|
| 233 |
Filed: 6/10/2002, Entered: 6/11/2002, Terminated: 6/11/2002 |
Motion for Extension |
|
All Cases MOTION with Memorandum in Support by Ranbaxy Laboratories, Ranbaxy, Teva Pharmaceuticals, Geneva to Extend Time To File Bill Of Costs with attached proposed order (cdod) Modified on 06/11/2002
|
|
|
|
|
|
| 232 |
Filed: 6/6/2002, Entered: 6/6/2002 |
Docket Annotation |
|
Copy of Transcript Purchase Order (of transcript already on file) by defendants (jcow)
|
|
|
|
|
|
| 231 |
Filed: 6/5/2002, Entered: 6/6/2002 |
Order |
|
Agreed ORDER granting [230-1] motion by Ranbaxy Laboratories, Ranbaxy, Teva Pharmaceuticals, Geneva to Extend Time to filed their respective bills of costs no later than 06/10/02; agreed, entered and filed 06/05/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 06/05/02 [EOD Date: 6/6/02] (cdod)
|
|
|
|
|
|
| 230 |
Filed: 6/3/2002, Entered: 6/4/2002, Terminated: 6/5/2002 |
Motion for Extension |
|
All Cases MOTION with Memorandum in Support by Ranbaxy Laboratories, Ranbaxy, Teva Pharmaceuticals, Geneva to Extend Time to File Bill Of Costs with attached proposed order (cdod) Modified on 06/04/2002
|
|
|
|
|
|
| -- |
Filed: 5/29/2002, Entered: 5/29/2002, Terminated: 1/13/2004 |
Transmission of Notice of Appeal to 4CCA |
|
Copy of Notice of Appeal, Judgment and docket sheet to USCA: copy of notice of appeal to plaintiff/appellant re: [229-1] appeal by Smithkline Beecham, Glaxosmithkline PLC; copy of notice of appeal to counsel of record; opinion/order not yet rendered by the court (jcow)
|
|
|
|
|
|
| 229 |
Filed: 5/28/2002, Entered: 5/28/2002, Terminated: 1/12/2004 |
Notice of Appeal |
|
NOTICE OF APPEAL by Glaxosmithkline PLC, Smithkline Beecham FILING FEE $ 105.00 RECEIPT # 34439 (jcow)
|
|
|
|
|
|
| 228 |
Filed: 5/23/2002, Entered: 5/24/2002 |
Judgment* |
|
JUDGMENT on decision by the Court that judgment is hereby entered in favor of the plaintiffs against the defendants as to the three patents, United States Patent Nos. 4,560,552, 4,525,352 and 4,529,720, which are found to be invalid upon the grounds of double patenting, ent. by the Clerk 5/23/02 and filed 5/23/02. Copies Mailed to cnsl. 5/24/02. ob. [EOD DATE: 5/24/02] (danc) Modified on 05/28/2002
|
|
|
|
|
|
| 227 |
Filed: 5/23/2002, Entered: 5/24/2002 |
Transcript |
|
All Cases TRANSCRIPT for dates of 05/23/02 Trial Proceedings Diane Gray, OCR (cdod)
|
|
|
|
|
|
| 226 |
Filed: 5/23/2002, Entered: 5/23/2002 |
Minutes-Miscellaneous |
|
Minute entry: BENCH TRIAL PROCEEDINGS CONTINUED (Day 4): HCM, Jr, j; Court Rptrs: Diane Gray, OCR, & Sandra Strom, Scopist/Assistant. Counsel app. Closing arguments heard. Court's findings & rulings read into record. Court to prepare a written opinion to further explain rulings. Court directs that judgment be entered in favor of plaintiffs against the dfts. as to the three patents, United States Patent Nos. 4,560,552, 4,525,352, and 4,529,720, which are found to be invalid upon the grounds of double patenting. (danc) Modified on 05/24/2002
|
|
|
|
|
|
| 225 |
Filed: 5/23/2002, Entered: 5/23/2002 |
Transcript |
|
TRANSCRIPT of Trial Proceedings (Volume 3) for date of 5/22/02, filed in open court. (danc)
|
|
|
|
|
|
| -- |
Filed: 5/23/2002, Entered: 5/23/2002 |
Bench Trial - Held |
|
Bench trial held (danc)
|
|
|
|
|
|
| 224 |
Filed: 5/22/2002, Entered: 5/23/2002 |
Transcript |
|
TRANSCRIPT of Trial Proceedings (Volume 2) for date of 5/21/02, filed. (danc)
|
|
|
|
|
|
| 223 |
Filed: 5/22/2002, Entered: 5/23/2002 |
Minutes-Miscellaneous |
|
Minute entry: BENCH TRIAL PROCEEDINGS CONTINUED (Day 3): HCM, Jr., j; Diane Gray, OCR, Sandra Strom, Scopist/ Assistant. Counsel app. Dfts. pres. evidence & rested. Parties excused until 5/23/02 at 10:00 AM. Adj. (danc)
|
|
|
|
|
|
| 221 |
Filed: 5/22/2002, Entered: 5/22/2002 |
Miscellaneous Document |
|
All Cases Memorandum of Law Concerning Improper Use of Specification by Glaxosmithkline PLC, Smithkline Beecham received (cdod)
|
|
|
|
|
|
| 220 |
Filed: 5/22/2002, Entered: 5/22/2002 |
Miscellaneous Document |
|
All Cases Bench Memorandum by Geneva, Teva Pharmaceuticals received (cdod)
|
|
|
|
|
|
| -- |
Filed: 5/22/2002, Entered: 5/22/2002 |
Bench Trial - Held |
|
Bench trial held (danc)
|
|
|
|
|
|
| 222 |
Filed: 5/21/2002, Entered: 5/22/2002 |
Minutes-Miscellaneous |
|
Minute entry: BENCH TRIAL PROCEEDINGS CONTINUED (Day 2): HCM, Jr, j; Court Rptrs: Diane Gray, OCR; (AM), Heidi Jeffries (PM); Sharon Gregory (evening); & (Sandra Strom, Scopiest/Assistant). Counsel app. Geneva completed pres. of evidence. Teva pres. evidence. Ranbaxy pres. no evidence. Ptfs. rested. Dfts.' oral motion for judgment as a matter of law; argued; DENIED. Dfts. pres. evidence in part. Parties excused until 5/22/02 at 9:30 AM. Adj. (danc)
|
|
|
|
|
|
| 219 |
Filed: 5/21/2002, Entered: 5/21/2002 |
Docket Annotation |
|
GENEVA PHARMACEUTICALS, INC.'S Proffer of Evidence filed in open court. (danc)
|
|
|
|
|
|
| 218 |
Filed: 5/21/2002, Entered: 5/21/2002 |
Transcript |
|
TRANSCRIPT of Trial Proceedings (Volume 1, pages 1 - 103 for dates of 5/20/02, filed in open court. (danc)
|
|
|
|
|
|
| 217 |
Filed: 5/21/2002, Entered: 5/21/2002 |
Deposition |
|
DEPOSITION of Martin Cole (excerpts) 1/31/02, filed in open court. (danc)
|
|
|
|
|
|
| -- |
Filed: 5/21/2002, Entered: 5/21/2002 |
Bench Trial - Held |
|
Bench trial held (danc)
|
|
|
|
|
|
 216 |
Filed: 5/20/2002, Entered: 5/21/2002 |
Minutes-Miscellaneous |
|
Minute entry: BENCH TRIAL PROCEEDINGS: HCM, Jr, j; Court Rptrs: Diane Gray, AM; Heidi Jeffries, PM; Sharon Gregory (evening); Sandra Strom, Scopiest/Assistant); app. by cnsl. as follows: Dimitrios T. Drivas, Conrad Shumadine, Leslie Morioka, Louis Silvestri & Adam Gahtan on behalf of Geneva; Alan Albert, Thomas Meloro, Kyle Musgrove, Larissa Soccoli & Rob Cerwinski on behalf of Teva; Linda Laibstain, Beth Berman & Kelly Mofield on behalf of Ranbaxy; & Stephen Noona, Donald Dunner, Richard Rainey, John Lowe, Michael McCabe, II & Jeff Mason on behalf of dfts. No app. in regard to Notice of Motion to Close Portions of Trial & Documents to be filed under seal, posted May 16, 2002. Motions will be heard at trial when issues arise which are subject of motions. Dfts. orally adv. Court that Teva's pending motion (#177) in limine to preclude GSK from relying on summary financial date, the testimony Brian Lortie & other evidence to prove commercial success at trial, will not be argued at trial & is moot. Dfts. orally advised Court that Geneva's motion (#174) in limine to preclude use of selected GSK attorney-client correspondence at trial, will not be argued at trial & is moot. (Remaining motions in limine #183 & #188 to be argued at appropriate time.) Dfts.' oral motion to exclude fact witnesses; GRANTED. Opening statements heard. Ptf. Geneva pres. evidence in part. Parties exc. until 5/21/02 at 9:30 AM. Adj. (danc)
|
|
|
|
|
|
| -- |
Filed: 5/20/2002, Entered: 5/21/2002 |
Bench Trial - Held |
|
Bench trial held (danc)
|
|
|
|
|
|
| 215 |
Filed: 5/17/2002, Entered: 5/17/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Ranbaxy, Ranbaxy Laboratories in support of [214-1] notice by Ranbaxy Laboratories, Ranbaxy for Joinder In The Motion To Close Courtroom For The Presentation Of Confidential Information received (cdod)
|
|
|
|
|
|
| 214 |
Filed: 5/17/2002, Entered: 5/17/2002 |
Notice |
|
All Cases NOTICE of by Ranbaxy Laboratories, Ranbaxy for Joinder In The Motion To Close Courtroom For The Presentation Of Confidential Information (cdod)
|
|
|
|
|
|
| 213 |
Filed: 5/16/2002, Entered: 5/17/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Glaxosmithkline PLC, Smithkline Beecham to response to [188-1] motion to Preclude Plaintiffs From Relying At Trial On References Whose Applicability Was Untimely Disclosed received (cdod)
|
|
|
|
|
|
| 212 |
Filed: 5/16/2002, Entered: 5/17/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Glaxosmithkline PLC, Smithkline Beecham to response to [183-1] motion in limine received (cdod)
|
|
|
|
|
|
| -- |
Filed: 5/15/2002, Entered: 5/16/2002 |
Proposed Findings of Fact |
|
All Cases PROPOSED FINDINGS OF FACT AND CONCLUSIONS OF LAW by Teva Pharmaceuticals received UNDER SEAL (cdod)
|
|
|
|
|
|
| 211 |
Filed: 5/14/2002, Entered: 5/16/2002 |
Notice |
|
All Cases NOTICE of Motion To Close Portions Of Trial by all parties and endorsed by Judge Henry Coke Morgan (cdod)
|
|
|
|
|
|
| 210 |
Filed: 5/14/2002, Entered: 5/15/2002 |
Affidavit |
|
AFFIDAVIT of Marc A. Goshko in support of oral motion by Teva Pharmaceuticals for leave to file findings of fact & conclusions of law under seal, filed in open court. (danc)
|
|
|
|
|
|
| 209 |
Filed: 5/14/2002, Entered: 5/15/2002 |
Minutes-Miscellaneous |
|
Minute entry: COURT PROCEEDINGS: HCM, Jr, j; Diane Gray, OCR; app. by Mr. Shumadine for Geneva, Mr. Albert for Teva & Mr. Noona for dfts. Came on for hearing on pending motions. Dfts'. motion to file exhibit under seal (#162); Teva's motion for entry of order granting leave to file certain exhibits under seal (#176); Teva's motion in limine to preclude GSK from relyig on summary financial data, etc. (#177); Teva's motion for entry of order granting leave to file certain exhibits under seal (#178); Teva's motion in limine to preclude GSK, etc. (#179); Dfts'. motion to file exhibits under seal (#192); Geneva's motion to file exhibit 1 todocument #174 under seal (#193); Teva's motion in limine to preclude GSK from relying on summary financial data (#194); Teva's motion for leave to file certain exhibits under seal (#196); Teva's motion for entry of order granting leave to file certain exhibits under seal (#199); & Geneva's motion to file exhibits under seal (#204). All motions GRANTED. Dfts.' motion for leave to file findings of fact & conclusions of law under seal (#201) joined in by Geneva & Teva, GRANTED. All parties' findings of fact & conclusions of law will be received under seal today, pending taking of objections May 20, 2002, at 9:15 AM. (Teva's Affidavit of Marc A. Goshko as evidence & in support of Teva's oral motion, filed in open court.) Rulings read into record & certain exhibits may be filed by counsel under seal. Counsel to present Notice of Motion to Close Portions of Trial for entry by the Court. Notice to be posted on bulletin board on May 16, 2002, at 4:00 PM. (danc)
|
|
|
|
|
|
| 208 |
Filed: 5/14/2002, Entered: 5/15/2002 |
Notice |
|
NOTICE by Glaxosmithkline PLC, Smithkline Beecham, Glaxosmithkline PLC for Hearing 5/14/02 re: motion for leave to file findings of fact & concluson of law under seal filed in open court. (danc)
|
|
|
|
|
|
| 207 |
Filed: 5/14/2002, Entered: 5/15/2002 |
Motion for Miscellaneous Relief |
|
MOTION with Memorandum in Support by Glaxosmithkline PLC, Smithkline Beecham, Glaxosmithkline PLC to close courtroom for presentation of confidential information with declaration of Stephen Venetianer attached filed in open court. (danc)
|
|
|
|
|
|
| 206 |
Filed: 5/14/2002, Entered: 5/15/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Geneva in support of [205-1] motion To Close Courtroom For The Presentation Of Confidential Information received (cdod)
|
|
|
|
|
|
| 205 |
Filed: 5/14/2002, Entered: 5/15/2002 |
Motion for Miscellaneous Relief |
|
All cases MOTION by Geneva To Close Courtroom For The Presentation Of Confidential Information (cdod)
|
|
|
|
|
|
| 204 |
Filed: 5/14/2002, Entered: 5/14/2002, Terminated: 7/19/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION with Memorandum in Support by Geneva To File Exhibits Under Seal (cdod)
|
|
|
|
|
|
| -- |
Filed: 5/14/2002, Entered: 5/15/2002 |
Motion Hearing |
|
Motion hearing held re: [204-1] motion by Geneva To File Exhibits Under Seal by Geneva, [201-1] motion by Smithkline Beecham, Glaxosmithkline PLCfor Leave to File findings of fact and conclusions of law under seal by Smithkline Beecham, Glaxosmithkline PLC, [199-1] motion by Teva Pharmaceuticals For Entry of Order Granting Leave To File Certain Exhibits Under Seal by Teva Pharmaceuticals, [194-1] motion by Teva Pharmaceuticals for Leave To Remove Exhibits From File by Teva Pharmaceuticals, [196-1] motion by Teva Pharmaceuticals for Leave to File certain exhibits under seal by Teva Pharmaceuticals, [193-1] motion by Geneva to File Exhibit 1 to Document #174 under seal by Geneva, [192-1] motion by Smithkline Beecham, Glaxosmithkline PLC To File Exhibits Under Seal by Smithkline Beecham, Glaxosmithkline PLC, [179-1] motion by Teva Pharmaceuticals in limine by Teva Pharmaceuticals, [178-1] motion by Teva Pharmaceuticals For Entry Of Order Granting Leave To File Certain Exhibits Under Seal by Teva Pharmaceuticals, [177-1] motion by Teva Pharmaceuticals in limine by Teva Pharmaceuticals, [176-1] motion by Teva Pharmaceuticals For Entry of Order Granting Leave To File Certain Exhibits Under Seal by Teva Pharmaceuticals, [162-1] motion by Smithkline Beecham, Glaxosmithkline PLC to File Exhibit Under Seal by Smithkline Beecham, Glaxosmithkline PLC (danc)
|
|
|
|
|
|
| -- |
Filed: 5/14/2002, Entered: 5/15/2002 |
Proposed Findings of Fact |
|
All CasesPROPOSED FINDINGS OF FACT AND CONCLUSIONS OF LAW by Geneva received UNDER SEAL (cdod)
|
|
|
|
|
|
| -- |
Filed: 5/14/2002, Entered: 5/15/2002 |
Proposed Findings of Fact |
|
All Cases PROPOSED FINDINGS OF FACT AND CONCLUSIONS OF LAW by Glaxosmithkline PLC, Smithkline Beecham received UNDER SEAL (cdod)
|
|
|
|
|
|
| 203 |
Filed: 5/13/2002, Entered: 5/14/2002 |
Response |
|
All Cases Response by Geneva to [188-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Preclude Plaintiffs From Relying At Trial On References Whose Applicability Was Untimely Disclosed received PLC (cdod)
|
|
|
|
|
|
| 202 |
Filed: 5/13/2002, Entered: 5/14/2002 |
Response |
|
All cases response by Geneva to [183-1] motion by Smithkline Beecham, Glaxosmithkline PLC in limine received (cdod)
|
|
|
|
|
|
| 201 |
Filed: 5/10/2002, Entered: 5/13/2002 |
Motion for Leave to File |
|
All Cases MOTION with Memorandum in Support by Smithkline Beecham, Glaxosmithkline PLCfor Leave to File findings of fact and conclusions of law under seal (cdod)
|
|
|
|
|
|
| 200 |
Filed: 5/10/2002, Entered: 5/13/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Teva Pharmaceuticals to response to [177-1] motion in limine received (cdod)
|
|
|
|
|
|
| 199 |
Filed: 5/10/2002, Entered: 5/13/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION by Teva Pharmaceuticals For Entry of Order Granting Leave To File Certain Exhibits Under Seal (cdod)
|
|
|
|
|
|
| 198 |
Filed: 5/10/2002, Entered: 5/10/2002 |
Order |
|
All Cases ORDER granting [194-1] motion by Teva Pharmaceuticals for Leave To Remove Exhibits From File; agreed, entered and filed 05/10/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 05/10/02 [EOD Date: 5/10/02] (cdod)
|
|
|
|
|
|
| 197 |
Filed: 5/9/2002, Entered: 5/10/2002 |
Reply to Response to Motion |
|
All Cases REPLY to response to [179-1] motion by Teva Pharmaceuticals in limine received (cdod)
|
|
|
|
|
|
| 196 |
Filed: 5/9/2002, Entered: 5/10/2002 |
Motion for Leave to File |
|
MOTION with Memorandum in Support by Teva Pharmaceuticals for Leave to File certain exhibits under seal (cdod)
|
|
|
|
|
|
| 195 |
Filed: 5/9/2002, Entered: 5/10/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Geneva to response to [174-1] motion in limine received (cdod)
|
|
|
|
|
|
| 194 |
Filed: 5/9/2002, Entered: 5/9/2002, Terminated: 5/10/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION by Teva Pharmaceuticals for Leave To Remove Exhibits From File (cdod)
|
|
|
|
|
|
| 193 |
Filed: 5/8/2002, Entered: 5/9/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION with Memorandum in Support by Geneva to File Exhibit 1 to Document #174 under seal (cdod) Modified on 05/09/2002
|
|
|
|
|
|
| 192 |
Filed: 5/7/2002, Entered: 5/8/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION with Memorandum in Support by Smithkline Beecham, Glaxosmithkline PLC To File Exhibits Under Seal (cdod) Modified on 05/09/2002
|
|
|
|
|
|
| 191 |
Filed: 5/7/2002, Entered: 5/8/2002 |
Memorandum in Opposition |
|
All Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in opposition to [177-1] motion by Teva Pharmaceuticals in limine received; exhibits 1-3 pending filed under seal (motion filed) (cdod)
|
|
|
|
|
|
| 190 |
Filed: 5/6/2002, Entered: 5/7/2002 |
Memorandum in Opposition |
|
All Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in opposition to [179-1] motion by Teva Pharmaceuticals in limine , [177-1] motion by Teva Pharmaceuticals in limine , [174-1] motion by Geneva in limine received (cdod)
|
|
|
|
|
|
| 189 |
Filed: 5/1/2002, Entered: 5/3/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in support of [188-1] motion to Preclude Plaintiffs From Relying At Trial On References Whose Applicability Was Untimely Disclosed received (cdod)
|
|
|
|
|
|
| 188 |
Filed: 5/1/2002, Entered: 5/3/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION by Smithkline Beecham, Glaxosmithkline PLC to Preclude Plaintiffs From Relying At Trial On References Whose Applicability Was Untimely Disclosed (cdod) Modified on 05/09/2002
|
|
|
|
|
|
| 187 |
Filed: 5/1/2002, Entered: 5/3/2002 |
Order |
|
All Cases Agreed ORDER granting [185-1] motion by Geneva For Leave To Remove Exhibits From File; agreed, entered and filed 05/01/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 05/03/02 [EOD Date: 5/3/02] (cdod) Modified on 05/03/2002
|
|
|
|
|
|
| 186 |
Filed: 5/1/2002, Entered: 5/3/2002 |
Order |
|
All Cases Agreed ORDER extending the time for Geneva to file its reply to motion to file an amended complaint until 04/04/02; agreed, entered and filed 05/01/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 05/03/02 [EOD Date: 5/3/02] (cdod)
|
|
|
|
|
|
| 185 |
Filed: 5/1/2002, Entered: 5/1/2002, Terminated: 5/1/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION by Geneva For Leave To Remove Exhibits From File (cdod) Modified on 05/01/2002
|
|
|
|
|
|
| 184 |
Filed: 4/30/2002, Entered: 5/1/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Glaxosmithkline PLC, Smithkline Beecham, Ranbaxy, Ranbaxy Laboratories to response to [165-1] motion For Certification Pursuant To Fed,R.Civ.P. 54(B) Of The Claims In Suit Relating To The 2000/01 Cole Patents received (cdod)
|
|
|
|
|
|
| 183 |
Filed: 4/30/2002, Entered: 5/1/2002 |
Motion in Limine |
|
All Cases MOTION with Memorandum in Support by Smithkline Beecham, Glaxosmithkline PLC in limine To Preclude Plaintiff's From Proferring Any Expert Testimony Relating to U.S. Patent Nos. 4,490,294 and 4,144,242 (cdod)
|
|
|
|
|
|
| 182 |
Filed: 4/30/2002, Entered: 5/1/2002 |
Transcript |
|
All Cases; Transcript for 04/26/02 Final Pretrial Conference; Diane Gray, OCR (cdod)
|
|
|
|
|
|
| 181 |
Filed: 4/26/2002, Entered: 4/29/2002 |
Order |
|
Order on Final Pretrial Conference signed by Judge Henry C. Morgan Jr. & filed in open court. Copies to counsel. (danc)
|
|
|
|
|
|
| 180 |
Filed: 4/26/2002, Entered: 4/29/2002 |
Minutes-Miscellaneous |
|
Minute entry: COURT PROCEEDINGS: HCM, Jr, j; Diane Gray, OCR; app. by cnsl. Came on for Final Pretrial Conference; arguement heard. Court's rulings read into record. Teva's two motions in limine filed today & dfts.' proposed motion in limine, if filed, shall be responded to according to Rules & may be ruled on by court on the pleadings prior to trial or taken up at trial. Final Pretrial Order filed in open court. Trial is rescheduled to begin at 9:15 am on May 20, 2002. Adj. (danc)
|
|
|
|
|
|
| 179 |
Filed: 4/26/2002, Entered: 4/29/2002 |
Motion in Limine |
|
All Cases MOTION with Memorandum in Support by Teva Pharmaceuticals in limine To Preclude GSK From Relying On Certain Documents Concerning Interference No. 100,451 (cdod)
|
|
|
|
|
|
| 178 |
Filed: 4/26/2002, Entered: 4/29/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION with Memorandum in Support by Teva Pharmaceuticals For Entry Of Order Granting Leave To File Certain Exhibits Under Seal (cdod)
|
|
|
|
|
|
| 177 |
Filed: 4/26/2002, Entered: 4/29/2002 |
Motion in Limine |
|
All Cases MOTION with Memorandum in Support by Teva Pharmaceuticals in limine To Preclude GSK From Relying On Summary Financial Date, The Testimony of Brian Lortie and Other Evidence To Prove Commercial Success At Trial (cdod)
|
|
|
|
|
|
| 176 |
Filed: 4/26/2002, Entered: 4/29/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION with Memorandum in Support by Teva Pharmaceuticals For Entry of Order Granting Leave To File Certain Exhibits Under Seal (cdod)
|
|
|
|
|
|
| -- |
Filed: 4/26/2002, Entered: 5/6/2002 |
Pretrial Conference - Final |
|
Pre-Trial Conference held (cdod)
|
|
|
|
|
|
| -- |
Filed: 4/26/2002, Entered: 4/29/2002 |
Pretrial Order |
|
Final Pre-trial Conference as to Geneva, Glaxosmithkline PLC, Smithkline Beecham, Glaxosmithkline PLC, Smithkline Beecham, Novartis AG, Biochemie GMBH, Geneva, Teva Pharmaceuticals, Glaxosmithkline PLC, Smithkline Beecham, Teva Pharmaceuticals, Ranbaxy, Ranbaxy Laboratories, Glaxosmithkline PLC, Smithkline Beecham, Glaxosmithkline PLC, Smithkline Beecham, Ranbaxy, Ranbaxy Laboratories, Ranbaxy, Ranbaxy Laboratories held (danc)
|
|
|
|
|
|
| -- |
Filed: 4/26/2002, Entered: 4/26/2002 |
Order |
|
So Ordered: granting [169-1] motion by Teva Pharmaceuticals for Cecil Kyle Musgrove to appear pro hac vice Filing Fee Paid $ 25.00 Receipt # 34061; entered 04/25/02 and filed 04/26/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 04/26/02 (cdod)
|
|
|
|
|
|
| -- |
Filed: 4/26/2002, Entered: 4/26/2002 |
Order |
|
So Ordered: granting [172-1] motion by Smithkline Beecham, Glaxosmithkline PLC for Geoffrey C. Mason to appear pro hac vice Filing Fee Paid $ 25.00 Receipt # 34073; entered 04/25/02 and filed 04/26/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 04/26/02 (cdod)
|
|
|
|
|
|
| 175 |
Filed: 4/25/2002, Entered: 4/26/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Geneva in support of [174-1] motion in limine received (cdod)
|
|
|
|
|
|
| 174 |
Filed: 4/25/2002, Entered: 4/26/2002 |
Motion in Limine |
|
All Cases MOTION with Memorandum in Support by Geneva in limine to Preclude Use of Selected GSK Attorney-Client Correspondence At trial (cdod)
|
|
|
|
|
|
| 173 |
Filed: 4/25/2002, Entered: 4/26/2002 |
Memorandum in Opposition |
|
All Cases MEMORANDUM by Geneva in opposition to [165-1] motion by Ranbaxy Laboratories, Ranbaxy, Smithkline Beecham, Glaxosmithkline PLC For Certification Pursuant To Fed,R.Civ.P. 54(B) Of The Claims In Suit Relating To The 2000/01 Cole Patents received (cdod)
|
|
|
|
|
|
| Save 25% on a pre-paid one year subscription. |
|
|
| 172 |
Filed: 4/24/2002, Entered: 4/25/2002 |
Motion for Pro Hac Vice |
|
MOTION by Smithkline Beecham, Glaxosmithkline PLC for Geoffrey C. Mason to appear pro hac vice Filing Fee Paid $ 25.00 Receipt # 34073 (cdod)
|
|
|
|
|
|
| 171 |
Filed: 4/24/2002, Entered: 4/24/2002 |
Transcript |
|
TRANSCRIPT for dates of 04/18/02 Telephone Conference; Gloria Smith, OCR (cdod)
|
|
|
|
|
|
| 169 |
Filed: 4/23/2002, Entered: 4/23/2002, Terminated: 4/26/2002 |
Motion for Pro Hac Vice |
|
MOTION by Teva Pharmaceuticals for Cecil Kyle Musgrove to appear pro hac vice Filing Fee Paid $ 25.00 Receipt # 34061 (cdod)
|
|
|
|
|
|
| 168 |
Filed: 4/22/2002, Entered: 4/22/2002 |
Order |
|
All Cases Opinion and ORDER granting [79-1] motion by Teva Pharmaceuticals for Summary Judgment of Patent Invalidity Due To Double Patenting; finding that '903, '977 and '703 patents are invalid on the ground of obviousness-type double patenting; entered and filed 04/22/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 04/22/02 [EOD Date: 4/22/02] (cdod) Modified on 04/22/2002
|
|
|
|
|
|
| -- |
Filed: 4/22/2002, Entered: 4/22/2002 |
Set/Clear Flags |
|
**Remove Jury Flag** (cdod)
|
|
|
|
|
|
| 170 |
Filed: 4/18/2002, Entered: 4/23/2002 |
Minutes-Miscellaneous |
|
Minute entry: TELEPHONE CONFERENCE CALL PROCEEDINGS: Henry Coke Morgan, Jr., j; Gloria Smith, OCR; app. via conf. call by D. Drivas, C. Shumadine & L. Morioka on behalf of ptf. Geneva; A. Albert & T. Meloro on behalf of ptf. Teva; B. Birman & J. Jennings on behalf of ptf. Ranbaxy. & S. Noona, D. Dunner, R. Rainey & S. Veneianer on behalf of dfts. Came on for telephone conference call status hearing; argument heard. Court's rulings read into record. Court confirmed jury had been waived; bench trial only. Case will be bifurcated first as to validity, then infringement. Judge to review discovery issues & USMJ's Order & adv. cnsl. Court's caution to Geneva re: discovery read into record. Joint mot. (#165) for Certification Pursuant to Fed.R.Civ. P. 54(B) to be considered by court when fully briefed. Court may give GSK opportunity to supplement record before it rules & will review as soon as possible. Court DENIES motion to amend complaint (#138) & will not address laches motion before trial. Adj. (danc)
|
|
|
|
|
|
| 167 |
Filed: 4/18/2002, Entered: 4/19/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Teva Pharmaceuticals to response to [153-1] motion for Protective Order received (cdod)
|
|
|
|
|
|
| -- |
Filed: 4/18/2002, Entered: 4/23/2002 |
Motion Hearing |
|
Motion hearing held re: [138-1] motion by Geneva for Leave to File second amended complaint by Geneva (danc)
|
|
|
|
|
|
| 166 |
Filed: 4/16/2002, Entered: 4/17/2002 |
Memorandum in Support |
|
MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham, Ranbaxy, Ranbaxy Laboratories in support of [165-1] motion For Certification Pursuant To Fed,R.Civ.P. 54(B) Of The Claims In Suit Relating To The 2000/01 Cole Patents received (cdod)
|
|
|
|
|
|
| 165 |
Filed: 4/16/2002, Entered: 4/17/2002 |
Motion for Miscellaneous Relief |
|
Joint MOTION by Ranbaxy Laboratories, Ranbaxy, Smithkline Beecham, Glaxosmithkline PLC For Certification Pursuant To Fed,R.Civ.P. 54(B) Of The Claims In Suit Relating To The 2000/01 Cole Patents (cdod)
|
|
|
|
|
|
| 164 |
Filed: 4/16/2002, Entered: 4/16/2002 |
Order |
|
ORDER that Dr. Mark Wentland be made available for an additional three hours of deposition in either Albany, New York, or New York, New York,a nd ordering Dr. Wentland to answer any questions regarding any substantive information, whether written or verbal, relied upon or considered by him when preparing his report; entered and filed 04/16/02 ( signed by Magistrate Judge Tommy E. Miller ) Copies Mailed: 04/16/02 [EOD Date: 4/16/02] (cdod)
|
|
|
|
|
|
| 163 |
Filed: 4/15/2002, Entered: 4/16/2002 |
Memorandum in Opposition |
|
All Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in opposition to [153-1] motion by Teva Pharmaceuticals for Protective Order received (cdod)
|
|
|
|
|
|
| 162 |
Filed: 4/15/2002, Entered: 4/16/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION with Memorandum in Support by Smithkline Beecham, Glaxosmithkline PLC to File Exhibit Under Seal (cdod) Modified on 04/17/2002
|
|
|
|
|
|
| 161 |
Filed: 4/12/2002, Entered: 4/15/2002 |
Remark |
|
Letter re: response to document filed by Novartis on 04/03/02 filed by defendant Glaxosmithkline PLC, defendant Smithkline Beecham (cdod)
|
|
|
|
|
|
| 160 |
Filed: 4/11/2002, Entered: 4/11/2002 |
Order |
|
All Cases ORDER that GSK may choose two in-house counsel to view discovery materials produced under the protective order; these counsel must agree not to prosecute or be involved in the prosecution of patent applications for antibiotics for a period of three years from the date of this order; entered and filed 04/11/02 ( signed by Magistrate Judge Tommy E. Miller ) Copies Mailed: 04/11/02 [EOD Date: 4/11/02] (cdod)
|
|
|
|
|
|
| 159 |
Filed: 4/10/2002, Entered: 4/11/2002 |
Remark |
|
Waiver of jury demand filed by plaintiff Geneva (cdod)
|
|
|
|
|
|
| 158 |
Filed: 4/8/2002, Entered: 4/8/2002 |
Minutes-Miscellaneous |
|
All Cases Minute entry: Tommy E. Miller USMJ presiding; Horace P. Weiss, CR; plaintiffs appeared through Conrad M. shumadine and Alan Dale Albert. Defendant appeared through Stephen Edward Noona. Came on for a hearing on the motion for protective order. Argument. Court made rulings on the record. Court will prepare an order. (cdod)
|
|
|
|
|
|
| 157 |
Filed: 4/4/2002, Entered: 4/4/2002 |
Notice of Hearing. |
|
All cases NOTICE of Hearing: for Friday, April 5, 2002 at 3:00 pm on motion for a protective order by GSK (cdod)
|
|
|
|
|
|
| 156 |
Filed: 4/4/2002, Entered: 4/4/2002 |
Notice of Hearing. |
|
All Cases NOTICE of Hearing: for Friday, April 5, 2002 at 3:00 pm on Geneva's moiton for a Protective order (cdod)
|
|
|
|
|
|
| -- |
Filed: 4/4/2002, Entered: 4/4/2002 |
Miscellaneous Document |
|
CASE REFERRED to Magistrate Judge Tommy E. Miller (afor)
|
|
|
|
|
|
| -- |
Filed: 4/4/2002, Entered: 4/4/2002 |
Motion Hearing |
|
Motion hearing [134-1] motion by Smithkline Beecham, Glaxosmithkline PLC for Protective Order set at 3:00 4/5/02, [132-1] motion by Geneva for Protective Order set at 3:00 4/5/02 (cdod)
|
|
|
|
|
|
| 155 |
Filed: 4/3/2002, Entered: 4/4/2002 |
Reply to Response to Motion |
|
All cases REPLY by Geneva to response to [138-1] motion for Leave to File second amended complaint received (cdod)
|
|
|
|
|
|
| 154 |
Filed: 4/3/2002, Entered: 4/4/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Teva Pharmaceuticals in support of [153-1] motion for Protective Order received (cdod)
|
|
|
|
|
|
| 153 |
Filed: 4/3/2002, Entered: 4/4/2002 |
Motion for Protective Order |
|
All Cases MOTION by Teva Pharmaceuticals for Protective Order (cdod)
|
|
|
|
|
|
| -- |
Filed: 4/3/2002, Entered: 4/3/2002 |
Order |
|
So Ordered: granting [149-1] motion by Smithkline Beecham, Glaxosmithkline PLC for Michael Joseph McCabe II to appear pro hac vice Filing Fee Paid $ 25.00 Receipt # 33763; entered and filed 04/03/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 04/03/02 (cdod)
|
|
|
|
|
|
| 152 |
Filed: 4/2/2002, Entered: 4/3/2002 |
Remark |
|
All cases response by defendant Glaxosmithkline PLC, defendant Smithkline Beecham to document filed by Geneva 03/18/02; objecting to the Court choosing not to bifurcate the matter; requesting permission to take discovery, and additional time to take that discovery from Novartis and Biochemie; requesting that the court rule on the objections to Judge Miller's order of 02/22/02; requesting that the Court schedule a telephone conference (cdod)
|
|
|
|
|
|
| 151 |
Filed: 4/2/2002, Entered: 4/2/2002 |
Order |
|
Agreed ORDER that GSK shall have through and including 04/01/02 to file its reply brief in support of GSK's Objections and in opposition to Geneva's Memorandum in opposition to GSK's Objections to Mag. Judge Miller's 02/22/02 Discovery Order and Teva's Memorandum in Opposition to GSk's Objections to Magistrate Judge Miller's 02/22/02 Discovery Order; agreed, entered 03/29/02 and filed 04/02/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 04/02/02 [EOD Date: 4/2/02] (cdod)
|
|
|
|
|
|
| 150 |
Filed: 4/1/2002, Entered: 4/2/2002 |
Miscellaneous Document |
|
All Cases Brief by Glaxosmithkline PLC, Smithkline Beecham in support of [140-1] objection by Smithkline Beecham, PLC received (cdod)
|
|
|
|
|
|
| 149 |
Filed: 4/1/2002, Entered: 4/2/2002 |
Motion for Pro Hac Vice |
|
MOTION by Smithkline Beecham, Glaxosmithkline PLC for Michael Joseph McCabe II to appear pro hac vice Filing Fee Paid $ 25.00 Receipt # 33763 (cdod)
|
|
|
|
|
|
| 148 |
Filed: 3/26/2002, Entered: 3/27/2002 |
Financial Disclosure Statement |
|
All Cases Financial Interest Disclosure Statement (Local Rule 7.1) by Glaxosmithkline PLC, Smithkline Beecham (cdod)
|
|
|
|
|
|
| 147 |
Filed: 3/25/2002, Entered: 3/26/2002 |
Memorandum in Opposition |
|
All Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in opposition to [138-1] motion by Geneva for Leave to File second amended complaint received (cdod)
|
|
|
|
|
|
| 146 |
Filed: 3/25/2002, Entered: 3/25/2002 |
Memorandum in Opposition |
|
2:01cv391 MEMORANDUM by Geneva in opposition to [140-1] objection by Smithkline Beecham, Glaxosmithkline PLC with exhibit A (sealed--exhibit only) received (cdod)
|
|
|
|
|
|
| 145 |
Filed: 3/22/2002, Entered: 3/22/2002 |
Memorandum in Opposition |
|
All Cases MEMORANDUM by Teva Pharmaceuticals in opposition to [140-1] objection by Smithkline Beecham, Glaxosmithkline PLC received (cdod)
|
|
|
|
|
|
| 144 |
Filed: 3/19/2002, Entered: 3/19/2002 |
Transcript |
|
TRANSCRIPT for dates of 03/13/02 Motion hearing on Motion by Teva for Summary Judgment, Second Motion by Teva for Summary Judgment, and Motions to Dismiss by Biochemie and Novartis; Diane Gray, OCR (cdod)
|
|
|
|
|
|
| 143 |
Filed: 3/18/2002, Entered: 3/18/2002 |
Remark |
|
Letter advising the Court of the terms of Stipulation that Geneva, Biochemie and Novartis will agree to regarding the judgment involving the validity of GSK's U.S. Patent Nos. 4,525,352, 4,529,720, and 4,560,552 filed by plaintiff Geneva, counter-defendant Novartis AG, counter-defendant Biochemie GMBH (cdod)
|
|
|
|
|
|
| -- |
Filed: 3/15/2002, Entered: 3/15/2002 |
Motion Hearing |
|
Motion hearing held re: [79-1] motion by Teva Pharmaceuticals for Summary Judgment of Patent Invalidity Due To Double Patenting by Teva Pharmaceuticals, [65-1] motion by Biochemie GMBH to Dismiss defendants' and counterplaintiffs' counterclaims for lack of personal jurisdiction and for failure to state a claim pursuant to Fed.R.Civ.P. 12(b) and 12(b)(6), respectively by Biochemie GMBH, [87-1] motion by Novartis AG to Dismiss Defendants' and Counterplaintiffs' Counterclaims For Lack of Personal Jurisdiction Pursuant to Fed.Civ.P.12(b)(2) by Novartis AG, [92-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Strike Jury Demands of Geneva And Ranbaxy by Smithkline Beecham, Glaxosmithkline PLC (danc)
|
|
|
|
|
|
| -- |
Filed: 3/15/2002, Entered: 3/18/2002 |
Docket Annotation |
|
"Corrected" copies of exhibits for document #140 (cdod)
|
|
|
|
|
|
| 142 |
Filed: 3/13/2002, Entered: 3/15/2002 |
Judgment* |
|
In All Three Cases, JUDGMENT on decision by the court that plaintiff Teva Pharmaceuticals's USA, Inc.'s second motion for summary judgment (document number 79) is GRANTED in respect to three patents. United States Patent Nos. 6,031,093, 6,048,977 and 6,051,703, are invalid for obvious double patenting in light of United States Patent No. 4,529,720, entered by the Clerk 3/13/02 and filed 3/15/02, Copies Mailed to cnsl. 3/15/02. [EOD DATE: 3/15/02] (danc) Modified on 05/28/2002
|
|
|
|
|
|
| 141 |
Filed: 3/13/2002, Entered: 3/15/2002 |
Minutes-Miscellaneous |
|
Minute entry: COURT PROCEEDINGS: HCM, Jr, j; Diane Gray, OCR; app. by Dimitrios T. Drivas, Conrad Shumadine & Leslie Morioka on behalf of ptf. Geneva; Thomas J. Melero, Alan Albert, Amy Hulina & Robert Cerwinsky on behalf of ptf. Teva; Beth Berman & Joseph Jennings on behalf of ptf. Ranbaxy, et al; & Donald R. Dunner, Richard L. Rainey, Stephen Noona & Adam Avrunin on behalf of dfts. Came on for hrg. on following motions; argued. In ALL THREE CASES, ptf. Teva Pharmaceutical's second motion for summary judgment of Patent Invalidity Due to Double Patenting (#79); Court GRANTS second motion for summary judgment in respect to three (3) patents. United States Patent Nos. 6,031,093, 6,048,977 & 6,051,703 are invalid for obvious double patenting in light of U.S.Patent No. 4,529,720. In 2:01cv391, Biochemnie GMGH's motion to dismiss defendants' & counterplaintiffs' counterclaims for lack of personal jurisdiction & for failure to state a claim purs. to FRCvP 12(b) & 12(b)(6) (#65); TAKEN UNDER ADVISEMENT. In ALL THREE (3) CASES, Novartis AG's motion to dismiss defendants' & counterplaintiffs' Counterclaims for Lack of Personal Jurisdiction purs. to FRCvP 12(b)(2) (#87); TAKEN UNDER ADVISEMENT. In ALL THREE (3) CASES, SmithklineBeecham, Glaxosmithkline PLC's motion to strike jury demands of Geneva & Ranbaxy (#92) to be decided by the court on the papers prev. filed. Court kept files & will prepare order. (danc)
|
|
|
|
|
|
| -- |
Filed: 3/13/2002, Entered: 3/19/2002 |
Set/Reset Hearings |
|
Hearing Deadline held (cdod)
|
|
|
|
|
|
| -- |
Filed: 3/13/2002, Entered: 3/15/2002 |
Motion Hearing |
|
Motion hearing held re: [79-1] motion by Teva Pharmaceuticals for Summary Judgment of Patent Invalidity Due To Double Patenting by Teva Pharmaceuticals, [65-1] motion by Biochemie GMBH to Dismiss defendants' and counterplaintiffs' counterclaims for lack of personal jurisdiction and for failure to state a claim pursuant to Fed.R.Civ.P. 12(b) and 12(b)(6), respectively by Biochemie GMBH, [87-1] motion by Novartis AG to Dismiss Defendants' and Counterplaintiffs' Counterclaims For Lack of Personal Jurisdiction Pursuant to Fed.Civ.P.12(b)(2) by Novartis AG, [92-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Strike Jury Demands of Geneva And Ranbaxy by Smithkline Beecham, Glaxosmithkline PLC (danc)
|
|
|
|
|
|
| 140 |
Filed: 3/11/2002, Entered: 3/12/2002 |
Objection |
|
All Cases OBJECTION by defendant Glaxosmithkline PLC, defendant Smithkline Beecham to [126-1] order (cdod)
|
|
|
|
|
|
| 139 |
Filed: 3/11/2002, Entered: 3/12/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Geneva in support of [138-1] motion for Leave to File second amended complaint received with attached proposed second amended complaint (cdod)
|
|
|
|
|
|
| 138 |
Filed: 3/11/2002, Entered: 3/12/2002 |
Motion for Leave to File |
|
All Cases MOTION by Geneva for Leave to File second amended complaint (cdod) Modified on 03/12/2002
|
|
|
|
|
|
| 137 |
Filed: 3/8/2002, Entered: 3/11/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Geneva to response to [132-1] motion for Protective Order received (cdod)
|
|
|
|
|
|
| 136 |
Filed: 3/8/2002, Entered: 3/11/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Glaxosmithkline PLC, Smithkline Beecham to response to [134-1] motion for Protective Order received (cdod)
|
|
|
|
|
|
| 135 |
Filed: 3/4/2002, Entered: 3/5/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in support of [134-1] motion for Protective Order received (cdod)
|
|
|
|
|
|
| 134 |
Filed: 3/4/2002, Entered: 3/5/2002 |
Motion for Protective Order |
|
All Cases MOTION by Smithkline Beecham, Glaxosmithkline PLC for Protective Order (cdod) Modified on 03/05/2002
|
|
|
|
|
|
| 133 |
Filed: 3/4/2002, Entered: 3/5/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Geneva in support of [132-1] motion by Geneva for Protective Order received (cdod)
|
|
|
|
|
|
| 132 |
Filed: 3/4/2002, Entered: 3/5/2002 |
Motion for Protective Order |
|
All Cases MOTION by Geneva for Protective Order Pursuant To Rule 26(c)(7) (cdod) Modified on 03/05/2002
|
|
|
|
|
|
| 131 |
Filed: 3/1/2002, Entered: 3/1/2002 |
Transcript |
|
TRANSCRIPT for dates of 02/22/02 Gloria S. Smith, OCR (cdod)
|
|
|
|
|
|
| 130 |
Filed: 2/26/2002, Entered: 2/27/2002 |
Notice of Hearing. |
|
All Cases NOTICE of Hearing: on defendant Novartis AG's motion to dismiss and defendant Biochemie GmbH's motion to dismiss set for 03/13/02 at 9:30 am (cdod)
|
|
|
|
|
|
| 129 |
Filed: 2/26/2002, Entered: 2/26/2002 |
Judgment* |
|
All Cases JUDGMENT that GSK's motion for partial summary judgment in reference to the '552 patent is GRANTED and Teva's motion for partial summary judgment in reference to the '380 is GRANTED; entered by the Clerk 02/25/02 and filed 02/26/02;ob Copies Mailed: 02/26/02 [EOD DATE: 2/26/02] (cdod) Modified on 02/26/2002
|
|
|
|
|
|
| 128 |
Filed: 2/25/2002, Entered: 2/26/2002 |
Order |
|
All Cases ORDER granting [54-1] motion by Teva Pharmaceuticals for Summary Judgment, granting [26-1] motion by Smithkline Beecham, Glaxosmithkline PLC for partial Summary Judgment ; entered and filed 02/25/02 signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 02/25/02 [EOD Date: 2/26/02] (cdod)
|
|
|
|
|
|
| 127 |
Filed: 2/25/2002, Entered: 2/26/2002 |
Order |
|
All Cases Agreed ORDER that the time for the parties to file reply memoranda is extended to and through 02/15/02; agreed, entered and filed 02/25/02 ( signed by Judge Henry C. Jr. ) Copies Mailed: 02/26/02 [EOD Date: 2/26/02] (cdod) Modified on 02/26/2002
|
|
|
|
|
|
| 126 |
Filed: 2/22/2002, Entered: 2/22/2002 |
Order |
|
All Cases ORDER granting [113-1] motion by Smithkline Beecham, Glaxosmithkline PLC To File Exhibits Under Seal, denying [100-1] motion by Smithkline Beecham, Glaxosmithkline PLC Compel, granting [99-1] motion by Glaxosmithkline PLC, Geneva to File Exhibits Under Seal, granting [97-1] motion by Geneva for Protective Order; entered and filed 02/22/02 ( signed by Magistrate Tommy E. Miller ) Copies Mailed: 02/22/02 [EOD Date: 2/22/02] (cdod)
|
|
|
|
|
|
| 125 |
Filed: 2/22/2002, Entered: 2/22/2002 |
Minutes-Miscellaneous |
|
All Cases Minute entry: USMJ Tommy Miller presiding; Gloria Smith, OCR; came on for motion to compel and motion for protective order. Plaintiff appeared through Conrad M. Shumadine, Adam Gahtan, Alan Albert and Thomas Melaro. Defendants appeared through Liam O'Grady, Stephen Noona and Richard Rainey. Court denied motion to compel and granted motion for a protective order. Rulings done on the record. Court to prepare an order. (cdod)
|
|
|
|
|
|
| -- |
Filed: 2/22/2002, Entered: 2/22/2002 |
Set/Clear Flags |
|
**Set Protective Order Flag. (cdod)
|
|
|
|
|
|
| -- |
Filed: 2/22/2002, Entered: 2/22/2002 |
Set/Reset Hearings |
|
Motion Hearing Deadline set 9:30 3/13/02 on Motion to Dismiss and Motions for Summary Judgment (cdod)
|
|
|
|
|
|
| -- |
Filed: 2/22/2002, Entered: 2/22/2002 |
Motion Hearing |
|
Motion hearing held re: [113-1] motion by Smithkline Beecham, Glaxosmithkline PLC To File Exhibits Under Seal by Smithkline Beecham, Glaxosmithkline PLC, [100-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Compel by Smithkline Beecham, Glaxosmithkline PLC, [99-1] motion by Glaxosmithkline PLC, Geneva to File Exhibits Under Seal by Glaxosmithkline PLC, Geneva, [97-1] motion by Geneva for Protective Order by Geneva (cdod)
|
|
|
|
|
|
| 124 |
Filed: 2/21/2002, Entered: 2/21/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Glaxosmithkline PLC, Smithkline Beecham to response to [111-1] motion for Limited Discovery Relating to This Court's Personal Jurisdiction Over Novartis AG received (cdod)
|
|
|
|
|
|
| -- |
Filed: 2/21/2002, Entered: 2/21/2002 |
Order |
|
So Ordered: granting [123-1] motion by Geneva for Adam Robert Gahtan to appear pro hac vice Filing Fee Paid $ 25.00 Receipt # 33263; entered and filed 02/21/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 02/21/02 (cdod)
|
|
|
|
|
|
| 123 |
Filed: 2/19/2002, Entered: 2/19/2002, Terminated: 2/21/2002 |
Motion for Pro Hac Vice |
|
MOTION by Geneva for Adam Robert Gahtan to appear pro hac vice Filing Fee Paid $ 25.00 Receipt # 33263 (cdod)
|
|
|
|
|
|
| -- |
Filed: 2/19/2002, Entered: 2/19/2002 |
Order |
|
So Ordered: granting [22-1] motion by Smithkline Beecham, Glaxosmithkline PLC for Ford Franklin Farabow for admission pro hac vice Filing Fee $ 25.00; Receipt #30681; entered 07/31/01 and filed 02/19/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 02/19/02 (cdod)
|
|
|
|
|
|
| 122 |
Filed: 2/15/2002, Entered: 2/19/2002 |
Motion for Miscellaneous Relief |
|
All cases MOTION with Memorandum in Support by Smithkline Beecham, Glaxosmithkline PLC To File Exhibits Under Seal (cdod)
|
|
|
|
|
|
| 121 |
Filed: 2/15/2002, Entered: 2/19/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Glaxosmithkline PLC, Smithkline Beecham to response to [100-1] motion to Compel received (cdod)
|
|
|
|
|
|
| 120 |
Filed: 2/15/2002, Entered: 2/15/2002 |
Memorandum in Opposition |
|
All Cases MEMORANDUM by Novartis AG in opposition to [111-1] motion by Smithkline Beecham, Glaxosmithkline PLC for Limited Discovery Relating to This Court's Personal Jurisdiction Over Novartis AG received (cdod)
|
|
|
|
|
|
| 120 |
Filed: 2/15/2002, Entered: 2/15/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Novartis AG to response to [87-1] motion to Dismiss Defendants' and Counterplaintiffs' Counterclaims For Lack of Personal Jurisdiction Pursuant to Fed.Civ.P.12(b)(2) received (cdod)
|
|
|
|
|
|
| 119 |
Filed: 2/15/2002, Entered: 2/15/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Geneva to response to [97-1] motion for Protective Order received (cdod)
|
|
|
|
|
|
| -- |
Filed: 2/15/2002, Entered: 2/15/2002 |
Order |
|
All Cases So Ordered: granting [118-1] motion by Teva Pharmaceuticals for Larissa Ann Soccoli to appear pro hac vice Filing Fee Paid $ 25.00; Receipt Number 33229; entered and filed 02/15/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 02/15/02 (cdod)
|
|
|
|
|
|
| -- |
Filed: 2/15/2002, Entered: 2/15/2002 |
Motion Hearing |
|
Motion hearing [113-1] motion by Smithkline Beecham, Glaxosmithkline PLC To File Exhibits Under Seal set at 9:00 2/22/02, [99-1] motion by Glaxosmithkline PLC, Geneva to File Exhibits Under Seal set at 9:00 2/22/02 (cdod)
|
|
|
|
|
|
| -- |
Filed: 2/15/2002, Entered: 2/15/2002 |
Motion Hearing |
|
Motion hearing [100-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Compel set at 9:00 2/22/02, [97-1] motion by Geneva for Protective Order set at 9:00 2/22/02 (cdod)
|
|
|
|
|
|
| 118 |
Filed: 2/14/2002, Entered: 2/14/2002, Terminated: 2/15/2002 |
Motion for Pro Hac Vice |
|
All Cases MOTION by Teva Pharmaceuticals for Larissa Ann Soccoli to appear pro hac vice Filing Fee Paid $ 25.00 (cdod)
|
|
|
|
|
|
| 117 |
Filed: 2/13/2002, Entered: 2/14/2002 |
Notice of Hearing. |
|
NOTICE of Hearing: on February 22, 2002 at 9:00 am on Defendants' Motion for an entry of an order in accordance with GSK's Motion to Compel Production of Documents and to Compel the Depositions of Persons with Knowledge of Geneva's ANDAS (cdod)
|
|
|
|
|
|
| 116 |
Filed: 2/12/2002, Entered: 2/14/2002 |
Notice of Hearing. |
|
NOTICE of Hearing: for February 22, 2002 at 9:00 am on Geneva's Motion for a Protective Order Pursuant to Fed.R.Civ.P. 26(c) (cdod)
|
|
|
|
|
|
| 115 |
Filed: 2/12/2002, Entered: 2/14/2002 |
Notice of Hearing. |
|
All Cases NOTICE of Hearing: for February 21, 2002 at 9:30 am on Novartis AG's Motion to Dismiss Defendants' and Counterplaintiffs' Counterclaims for Lack of Personal Jurisdiction Pursuant to Fed.R.Civ.P.12(b)(2) and Biochemie G mb H's Motion to Dismiss Defendants' and Counterplaintiffs' Counterclaims for Lack of Personal Jurisdiction and For Failure to State a Claim Pursuant to Fed.R.Civ.P. 12(b)(2) (cdod)
|
|
|
|
|
|
| 114 |
Filed: 2/11/2002, Entered: 2/12/2002 |
Memorandum in Opposition |
|
All Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in opposition to [97-1] motion by Geneva for Protective Order received (cdod)
|
|
|
|
|
|
| 113 |
Filed: 2/11/2002, Entered: 2/12/2002, Terminated: 2/22/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION with Memorandum in Support by Smithkline Beecham, Glaxosmithkline PLC To File Exhibits Under Seal (cdod)
|
|
|
|
|
|
| 112 |
Filed: 2/11/2002, Entered: 2/12/2002 |
Memorandum in Opposition |
|
All Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in opposition to [87-1] motion by Novartis AG to Dismiss Defendants' and Counterplaintiffs' Counterclaims For Lack Personal Jurisdiction Pursuant to Fed.Civ.P.12(b)(2) received (cdod)
|
|
|
|
|
|
| 112 |
Filed: 2/11/2002, Entered: 2/12/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in support of [111-1] motion by Smithkline Beecham, Glaxosmithkline PLC for Limited Discovery Relating to This Court's Personal Jurisdiction Over Novartis AG received (cdod)
|
|
|
|
|
|
| 111 |
Filed: 2/11/2002, Entered: 2/12/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION by Smithkline Beecham, Glaxosmithkline PLC for Limited Discovery Relating to This Court's Personal Jurisdiction Over Novartis AG (cdod)
|
|
|
|
|
|
| 110 |
Filed: 2/11/2002, Entered: 2/12/2002 |
Memorandum in Opposition |
|
All Cases MEMORANDUM by Teva Pharmaceuticals in opposition to [100-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Compel received (cdod)
|
|
|
|
|
|
| 109 |
Filed: 2/11/2002, Entered: 2/12/2002 |
Memorandum in Opposition |
|
All Cases MEMORANDUM by Geneva in opposition to [100-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Compel received (cdod) Modified on 02/12/2002
|
|
|
|
|
|
| 108 |
Filed: 2/11/2002, Entered: 2/11/2002 |
Order |
|
All Cases Agreed ORDER granting [20-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Extend Time for GSK to file its opposition to Novartis AG's Motion to Dismiss; agreed, entered and filed 02/11/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 02/11/02 [EOD Date: 2/11/02] (cdod)
|
|
|
|
|
|
| -- |
Filed: 2/11/2002, Entered: 2/11/2002 |
Order |
|
All Cases So Ordered: granting [106-1] motion by Ranbaxy Laboratories, Ranbaxy for Christy Lynn Green to appear pro hac vice Filing Fee Paid $ 25.00 entered and filed 02/11/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 02/11/02 (cdod)
|
|
|
|
|
|
| -- |
Filed: 2/11/2002, Entered: 2/11/2002 |
Order |
|
All Cases So Ordered: granting [105-1] motion by Ranbaxy Laboratories, Ranbaxy for Joseph Francis Jennings to appear pro hac vice Filing Fee Paid $ 25.00; entered and filed 02/11/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 02/11/02 (cdod)
|
|
|
|
|
|
| 107 |
Filed: 2/8/2002, Entered: 2/11/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Glaxosmithkline PLC, Smithkline Beecham to response to [92-1] motion to Strike Jury Demands of Geneva And Ranbaxy received (cdod)
|
|
|
|
|
|
| 106 |
Filed: 2/6/2002, Entered: 2/6/2002, Terminated: 2/11/2002 |
Motion for Pro Hac Vice |
|
MOTION by Ranbaxy Laboratories, Ranbaxy for Christy Lynn Green to appear pro hac vice Filing Fee Paid $ 25.00 (cdod)
|
|
|
|
|
|
| 105 |
Filed: 2/6/2002, Entered: 2/6/2002, Terminated: 2/11/2002 |
Motion for Pro Hac Vice |
|
MOTION by Ranbaxy Laboratories, Ranbaxy for Joseph Francis Jennings to appear pro hac vice Filing Fee Paid $ 25.00 (cdod)
|
|
|
|
|
|
| 104 |
Filed: 2/5/2002, Entered: 2/6/2002 |
Memorandum in Opposition |
|
All Cases MEMORANDUM by Geneva in opposition to [92-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Strike Jury Demands of Geneva And Ranbaxy received (cdod)
|
|
|
|
|
|
| 103 |
Filed: 2/5/2002, Entered: 2/5/2002 |
Notice |
|
All Cases NOTICE of Non-Opposition To GSK's Motion to Strike Ranbaxy's Jury Demand by Ranbaxy, Ranbaxy Laboratories (cdod) Modified on 02/05/2002
|
|
|
|
|
|
| 102 |
Filed: 2/1/2002, Entered: 2/4/2002 |
Reply to Response to Motion |
|
All Cases REPLY by Teva Pharmaceuticals to response to [79-1]second motion for Summary Judgment of Patent Invalidity Due To Double Patenting received (cdod)
|
|
|
|
|
|
| 101 |
Filed: 1/31/2002, Entered: 2/1/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in support of [100-1] motion to Compel received (cdod)
|
|
|
|
|
|
| 100 |
Filed: 1/31/2002, Entered: 2/1/2002 |
Motion to Compel |
|
MOTION by Smithkline Beecham, Glaxosmithkline PLC to Compel Production Of Documents And to Compel The Depositions of Persons With Knowledge Of Geneva's Products (cdod)
|
|
|
|
|
|
| 99 |
Filed: 1/31/2002, Entered: 2/1/2002 |
Motion for Miscellaneous Relief |
|
All Cases MOTION with Memorandum in Support by Glaxosmithkline PLC, Geneva to File Exhibits Under Seal (cdod)
|
|
|
|
|
|
| 98 |
Filed: 1/31/2002, Entered: 2/1/2002 |
Affidavit |
|
2:01cv391 DECLARATION in support of Memorandum in Support of Motion for a Protective Order (cdod)
|
|
|
|
|
|
| 98 |
Filed: 1/31/2002, Entered: 2/1/2002 |
Memorandum in Support |
|
2:01cv391 MEMORANDUM by Geneva in support of [97-1] motion for Protective Order received (cdod)
|
|
|
|
|
|
| 97 |
Filed: 1/31/2002, Entered: 2/1/2002 |
Motion for Protective Order |
|
2:01cv391 MOTION by Geneva for Protective Order (cdod)
|
|
|
|
|
|
| 96 |
Filed: 1/31/2002, Entered: 2/1/2002 |
Miscellaneous Document |
|
All Cases Reply by Ranbaxy, Ranbaxy Laboratories to [90-1] counter claim by Smithkline Beecham, Glaxosmithkline PLC received (cdod)
|
|
|
|
|
|
| 95 |
Filed: 1/29/2002, Entered: 1/29/2002 |
Order |
|
All Cases Agreed ORDER granting [94-1] motion by Teva Pharmaceuticals to Extend Time to file its reply brief to GSK's Brief opposing Teva's second motion for summary judgment set Respond Deadline 2/1/02 agreed and entered 01/28/02 and filed 01/29/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 01/29/02 [EOD Date: 1/29/02] (cdod)
|
|
|
|
|
|
| Save 25% on a pre-paid one year subscription. |
|
|
| -- |
Filed: 1/29/2002, Entered: 1/29/2002 |
Order |
|
All Cases So Ordered: granting [89-1] motion by Smithkline Beecham, Glaxosmithkline PLC for Russell Leon Sandidge to appear pro hac vice Filing Fee Paid $ 25.00 Receipt # 32966; ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 01/29/02 (cdod) Modified on 01/29/2002
|
|
|
|
|
|
| 94 |
Filed: 1/25/2002, Entered: 1/25/2002, Terminated: 1/29/2002 |
Motion for Extension |
|
MOTION by Teva Pharmaceuticals to Extend Time Within Which To File A Reply Brief To GSK's Brief Opposing Teva's Second Motion For Summary Judgment Of Patent Invalidity Due To Double Patenting (cdod)
|
|
|
|
|
|
| 93 |
Filed: 1/25/2002, Entered: 1/25/2002 |
Affidavit |
|
All Cases AFFIDAVIT of Adam Avrunin Re: [93-1] support memorandum by Smithkline Beecham, Glaxosmithkline PLC (cdod)
|
|
|
|
|
|
| 93 |
Filed: 1/25/2002, Entered: 1/25/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in support of [92-1] motion to Strike Jury Demands of Geneva And Ranbaxy received (cdod)
|
|
|
|
|
|
| 92 |
Filed: 1/25/2002, Entered: 1/25/2002, Terminated: 7/19/2002 |
Motion to Strike |
|
All Cases MOTION by Smithkline Beecham, Glaxosmithkline PLC to Strike Jury Demands of Geneva And Ranbaxy (cdod) Modified on 01/25/2002
|
|
|
|
|
|
| 91 |
Filed: 1/25/2002, Entered: 1/25/2002 |
Summons Returned Executed |
|
All Cases SUMMONS Returned Executed as to Ranbaxy, Ranbaxy Laboratories 12/18/01 for counterclaim by Glaxosmithkline and Smithkline Beecham (cdod)
|
|
|
|
|
|
| 90 |
Filed: 1/25/2002, Entered: 1/25/2002 |
Counterclaim |
|
All Cases COUNTERCLAIM by defendant Glaxosmithkline PLC, defendant Smithkline Beecham against consolidated plaintiff Ranbaxy, consolidated plaintiff Ranbaxy Laboratories Ranbaxy, Laboratories filed in 2:01cv925 as document #11 on 01/11/02 (cdod) Modified on 01/25/2002
|
|
|
|
|
|
| 89 |
Filed: 1/25/2002, Entered: 1/25/2002, Terminated: 1/29/2002 |
Motion for Pro Hac Vice |
|
All Cases MOTION by Smithkline Beecham, Glaxosmithkline PLC for Russell Leon Sandidge to appear pro hac vice Filing Fee Paid $ 25.00 (cdod) Modified on 01/25/2002
|
|
|
|
|
|
| 88 |
Filed: 1/23/2002, Entered: 1/23/2002 |
Memorandum in Support |
|
All Cases MEMORANDUM by Novartis AG in support of [87-1] motion by Novartis AG to Dismiss Defendants' and Counterplaintiffs' Counterclaims For Lack of Personal Jurisdiction Pursuant to Fed.Civ.P.12(b)(2) received (cdod)
|
|
|
|
|
|
| 87 |
Filed: 1/23/2002, Entered: 1/23/2002, Terminated: 7/19/2002 |
Motion to Dismiss |
|
All Cases MOTION by Novartis AG to Dismiss Defendants' and Counterplaintiffs' Counterclaims For Lack of Personal Jurisdiction Pursuant to Fed.Civ.P.12(b)(2) (cdod) Modified on 01/23/2002
|
|
|
|
|
|
| 86 |
Filed: 1/22/2002, Entered: 1/23/2002 |
Memorandum in Opposition |
|
All CASES MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in opposition to [79-1] motion by Teva Pharmaceuticals for Summary Judgment of Patent Invalidity Due To Double Patenting received (cdod)
|
|
|
|
|
|
| 85 |
Filed: 1/16/2002, Entered: 1/17/2002 |
Order |
|
All Cases Agreed ORDER granting [72-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Extend Time for GSK to file its Brief in Support of Motion to Take Limited Discovery RElating to Personal Jurisdiction; agreed, entered and 01/16/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 01/17/02 [EOD Date: 1/17/02] (cdod) Modified on 01/17/2002
|
|
|
|
|
|
| 84 |
Filed: 1/16/2002, Entered: 1/17/2002 |
Order |
|
All Cases Agreed ORDER that Novartis may file responsive pleadings to the Counterclaim filed by 01/21/02; agreed, entered and filed 01/16/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 01/17/02 [EOD Date: 1/17/02] (cdod) Modified on 01/17/2002
|
|
|
|
|
|
| 83 |
Filed: 1/16/2002, Entered: 1/17/2002 |
Order |
|
All Cases Agreed ORDER that Exhibits 10-13 of GSK's Opposition Brief shall be SEALED; agreed, entered and filed 01/16/02 ( by Judge Henry C. Morgan Jr. ) Copies Mailed: 01/17/02 [EOD Date: 1/17/02] (cdod) Modified on 01/17/2002
|
|
|
|
|
|
| 82 |
Filed: 1/16/2002, Entered: 1/17/2002 |
Order |
|
Agreed ORDER Consolidating Cases 2:01cv925 with 2:01cv391 and 2:01cv677; agreed, entered and filed 01/16/02 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 01/17/02 [EOD Date: 1/17/02] (cdod)
|
|
|
|
|
|
| -- |
Filed: 1/16/2002, Entered: 1/17/2002 |
Set/Clear Flags |
|
Consolidated Lead Case (cdod)
|
|
|
|
|
|
| 81 |
Filed: 1/9/2002, Entered: 1/11/2002 |
Transcript |
|
TRANSCRIPT for dates of 01/02/02 by Diane M. Gray, OCR (cdod)
|
|
|
|
|
|
| 80 |
Filed: 1/8/2002, Entered: 1/9/2002 |
Memorandum in Support |
|
Both Cases MEMORANDUM by Teva Pharmaceuticals in support of [79-1] motion for Summary Judgment of Patent Invalidity Due To Double Patenting received (cdod) Modified on 01/09/2002
|
|
|
|
|
|
| 79 |
Filed: 1/8/2002, Entered: 1/9/2002, Terminated: 4/22/2002 |
Motion for Summary Judgment |
|
Both Cases Second MOTION by Teva Pharmaceuticals for Summary Judgment of Patent Invalidity Due To Double Patenting (cdod) Modified on 01/09/2002
|
|
|
|
|
|
| 78 |
Filed: 1/7/2002, Entered: 1/8/2002 |
Memorandum in Support |
|
Both Cases MEMORANDUM in support of [72-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Extend Time received (cdod) Modified on 01/08/2002
|
|
|
|
|
|
| 78 |
Filed: 1/7/2002, Entered: 1/8/2002 |
Memorandum in Opposition |
|
Both Cases MEMORANDUM in opposition to [65-1] motion by Biochemie GMBH to Dismiss defendants' and counterplaintiffs' counterclaims for lack personal jurisdiction and for failure to state a claim pursuant to Fed.R.Civ.P. 12(b) and 12(b)(6), respectively received (cdod) Modified on 01/08/2002
|
|
|
|
|
|
| 77 |
Filed: 1/7/2002, Entered: 1/8/2002 |
Reply to Response to Motion |
|
Both Cases REPLY to response to [72-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Extend Time received (cdod) Modified on 01/08/2002
|
|
|
|
|
|
| 76 |
Filed: 1/2/2002, Entered: 1/2/2002 |
Minutes-Miscellaneous |
|
Minute entry: COURT PROCEEDING: HCM, Jr., j; Diane Gray, OCR. App. by cnsl. C. Shumadine on behalf of ptf. Geneva, A. Albert on behalf of ptf. Teva, & S. Noona on behalf of dfts. Came on for hrg. on dfts. Glaxosmithkline & Smithkline Beecham's motion for leave to file 4 exhibits under seal to accompany dfts.' motion (#72) to extend time to file a brief in opposition to motion to dismiss, etc. (which motion (#72) has already been filed & response thereto received (#74)); argued; GRANTED. Cnsl. to circulate & submit order allowing filing of 4 exhibits under seal with reconstituted pleading & 4 exhibits. Adj. (danc)
|
|
|
|
|
|
| -- |
Filed: 1/2/2002, Entered: 1/2/2002 |
Motion Hearing |
|
Motion hearing held re: defendants Glaxosmthkline & Smithline Beecham's motion for leave to file four (4) exhibits under seal to accompany dfts.' motion (#72) which has already been filed & response (#74) received. (danc)
|
|
|
|
|
|
| 75 |
Filed: 12/28/2001, Entered: 12/28/2001 |
Notice of Hearing. |
|
Both cases NOTICE of Hearing: Set on 01/02/02 at 12:00 pm (cdod)
|
|
|
|
|
|
| 74 |
Filed: 12/21/2001, Entered: 12/27/2001 |
Memorandum in Opposition |
|
2:01cv391 MEMORANDUM by Biochemie GMBH in opposition to [72-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Extend Time received (cdod)
|
|
|
|
|
|
| 74 |
Filed: 12/21/2001, Entered: 12/27/2001 |
Reply to Response to Motion |
|
REPLY by Biochemie GMBH to response to [65-1] motion by Biochemie GMBH to Dismiss defendants' and counterplaintiffs' counterclaims for lack of personal jurisdiction and for failure to state a claim pursuant to Fed.R.Civ.P. 12(b) and 12(b)(6), respectively received (cdod)
|
|
|
|
|
|
| 73 |
Filed: 12/21/2001, Entered: 12/21/2001 |
Transcript |
|
***BOTH CASES***TRANSCRIPT for dates of December 14, 2001 before the Honorable Henry Coke Morgan, Jr. (clerk)
|
|
|
|
|
|
| 72 |
Filed: 12/14/2001, Entered: 12/17/2001, Terminated: 1/16/2002 |
Motion for Extension |
|
Both Cases MOTION with Memorandum in Support by Smithkline Beecham, Glaxosmithkline PLC to Extend Time to file a brief in opposition to motion to dismiss and for order allowing defendants-counterplaintiffs to take limited discovery relating to personal jurisdiction (cdod)
|
|
|
|
|
|
| 71 |
Filed: 12/14/2001, Entered: 12/17/2001 |
Judgment* |
|
JUDGMENT on decision by court that plaintiff, Teva Pharmaceuticals USA, Inc.'s motion for summary judgment (document number 54) is GRANTED IN PART; and that the defendants, Glaxosmithkline PLC and Smithkline Beecham Corporation d/b/a Glaxosmithkline Inc.'s cross motion for partial summary judgment (document number 56) is GRANTED IN PART, ent. by the Clerk & filed 12/14/01. Copies Mailed: 12/17/01 to cnsl. ob [EOD DATE: 12/17/01] (danc) Modified on 05/28/2002
|
|
|
|
|
|
| 70 |
Filed: 12/14/2001, Entered: 12/14/2001 |
Minutes-Miscellaneous |
|
Minute entry: COURT PROCEEDING: HCM, Jr, j; Diane Gray, OCR. Thomas J. Meloro, Alan Albert & Amy Hulina app. on behalf of ptf. Teva Pharmaceuticals; Donald R. Dunner, Richard L. Rainey, Kelly Casey & Stephen Noona app. on behalf of dfts. Glaxosmithkline & Smithkline Beecham; also present, but not participating in hrg. were Dimitrois T. Drivas, Conrad Shumadine & Leslie Morioka on behalf of ptf. Geneva). Came on for hrg. on following motions, which were argued. Ptf. Teva Pharmaceutical's motion for summary judgment (#54); GRANTED IN PART. Dfts.' Glaxosmithkline PLC & Smithkline Beecham Corporation's cross motion for partial summary judgment (#56): GRANTED IN PART. Court's comments & rulings read into record. Court orders that judgment be entered today in accordance with court's ruling. Court to prepare written opinion & kept files. (danc)
|
|
|
|
|
|
| -- |
Filed: 12/14/2001, Entered: 12/14/2001 |
Motion Hearing |
|
Motion hearing held re: [54-1] motion by Teva Pharmaceuticals for Summary Judgment by Teva Pharmaceuticals, [56-1] cross motion by Smithkline Beecham, Glaxosmithkline PLC for Partial Summary Judgment by Smithkline Beecham, Glaxosmithkline PLC (danc)
|
|
|
|
|
|
| -- |
Filed: 12/7/2001, Entered: 12/7/2001 |
Motion Hearing |
|
Motion hearing re: [56-1] cross motion by Smithkline Beecham, Glaxosmithkline PLC for Partial Summary Judgment set at 10:30 12/14/01, [54-1] motion by Teva Pharmaceuticals for Summary Judgment set at 10:30 12/14/01, [40-1] motion by Geneva for Summary Judgment set at 10:30 12/14/01, [26-1] motion by Smithkline Beecham, Glaxosmithkline PLC for partial Summary Judgment set at 10:30 12/14/01, [16-1] motion by Geneva for Summary Judgment set at 10:30 12/14/01 (cdod)
|
|
|
|
|
|
| -- |
Filed: 12/4/2001, Entered: 12/5/2001 |
Docket Annotation |
|
Letter to Judge Morgan re: five potential experts for the Court's consideration. Information packages for each expert. (cdod)
|
|
|
|
|
|
| 69 |
Filed: 11/29/2001, Entered: 11/30/2001 |
Reply to Response to Motion |
|
Both Cases REPLY by Glaxosmithkline PLC to response to [56-1] cross motion for Partial Summary Judgment received. (cdod)
|
|
|
|
|
|
| 68 |
Filed: 11/26/2001, Entered: 11/26/2001 |
Financial Disclosure Statement |
|
Financial Interest Disclosure Statement (Local Rule 7.1) by Teva Pharmaceuticals, Teva Pharmaceuticals (cdod)
|
|
|
|
|
|
| -- |
Filed: 11/20/2001, Entered: 11/21/2001 |
Order |
|
So Ordered: granting [62-1] motion by Teva Pharmaceuticals for Thomas J. Meloro to appear pro hac vice Filing Fee Paid $ 25.00 Receipt # 32158; entered 11/19/01 and filed 11/20/01 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 11/21/01 (cdod)
|
|
|
|
|
|
| -- |
Filed: 11/20/2001, Entered: 11/21/2001 |
Order |
|
So Ordered: granting [61-1] motion by Teva Pharmaceuticals for Steven Jeffrey Lee to appear pro hac vice Filing Fee Paid $ 25.00 Receipt # 32158; entered 11/19/01 and filed 11/20/01 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 11/21/01 (cdod)
|
|
|
|
|
|
| -- |
Filed: 11/20/2001, Entered: 11/21/2001 |
Order |
|
So Ordered: granting [60-1] motion by Teva Pharmaceuticals for Jeremiah Francis Manning to appear pro hac vice Filing Fee Paid $ 25.00 Receipt # 32158; entered 11/19/01 and filed 11/20/01 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 11/21/01 (cdod)
|
|
|
|
|
|
| 67 |
Filed: 11/19/2001, Entered: 11/20/2001 |
Affidavit |
|
2:01cv391 DECLARATION of Beth Brannan in support of Memorandum in Support of Motion by Biochemie GmbH to Dismiss (cdod)
|
|
|
|
|
|
| 66 |
Filed: 11/19/2001, Entered: 11/20/2001 |
Memorandum in Support |
|
2:01cv391 MEMORANDUM by Biochemie GMBH in support of [65-1] motion to Dismiss defendants' and counterclaims for lack of personal jurisdiction and for failure to state a claim pursuant to Fed.R.Civ.P. 12(b) and 12(b)(6), respectively received (cdod)
|
|
|
|
|
|
| 65 |
Filed: 11/19/2001, Entered: 11/20/2001 |
Motion to Dismiss |
|
2:01cv391 MOTION by Biochemie GMBH to Dismiss defendants' and counterplaintiffs' counterclaims for lack of personal jurisdiction and for failure to state a claim pursuant to Fed.R.Civ.P. 12(b) and 12(b)(6), respectively (cdod)
|
|
|
|
|
|
| 64 |
Filed: 11/19/2001, Entered: 11/19/2001 |
Order |
|
Agreed ORDER that the parties agree the reference in the 10/11/01 stipulation to the Geneva Lawsuit is and shall be deemed nunc pro tunc to that lawsuit styled Geneva Pharmaceuticals, Inc. v. Glaxosmithkline PLC, and SmithKline Beecham Corp. d/b/a Glaxosmithkline Inc., Civil Action No.: 2:01cv391; agreed, entered and filed 11/19/01 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 11/19/01 [EOD Date: 11/19/01] (cdod)
|
|
|
|
|
|
| 63 |
Filed: 11/19/2001, Entered: 11/19/2001 |
Order |
|
Agreed ORDER granting [58-1] motion by Teva Pharmaceuticals, Smithkline Beecham, Glaxosmithkline PLC, Smithkline Glaxosmithkline PLC to Extend Time Within Which To File Certain Objections and Pleadings; agreed, entered and filed 11/19/01 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 11/19/01 [EOD Date: 11/19/01] (cdod)
|
|
|
|
|
|
| 62 |
Filed: 11/19/2001, Entered: 11/19/2001, Terminated: 11/20/2001 |
Motion for Pro Hac Vice |
|
Both Cases MOTION by Teva Pharmaceuticals for Thomas J. Meloro to appear pro hac vice Filing Fee Paid $ 25.00 (cdod) Modified on 11/19/2001
|
|
|
|
|
|
| 61 |
Filed: 11/19/2001, Entered: 11/19/2001, Terminated: 11/20/2001 |
Motion for Pro Hac Vice |
|
Both Cases MOTION by Teva Pharmaceuticals for Steven Jeffrey Lee to appear pro hac vice Filing Fee Paid $ 25.00 (cdod) Modified on 11/19/2001
|
|
|
|
|
|
| 60 |
Filed: 11/19/2001, Entered: 11/19/2001, Terminated: 11/20/2001 |
Motion for Pro Hac Vice |
|
Both Cases MOTION by Teva Pharmaceuticals for Jeremiah Francis Manning to appear pro hac vice Filing Fee Paid $ 25.00 (cdod) Modified on 11/19/2001
|
|
|
|
|
|
| 59 |
Filed: 11/16/2001, Entered: 11/19/2001 |
Memorandum in Opposition |
|
Both Cases MEMORANDUM by Teva Pharmaceuticals in opposition to [56-1] cross motion by Smithkline Beecham, Glaxosmithkline PLC for Partial Summary Judgment received (cdod)
|
|
|
|
|
|
| 59 |
Filed: 11/16/2001, Entered: 11/19/2001 |
Reply to Response to Motion |
|
Both Cases REPLY by Teva Pharmaceuticals to response to [54-1] motion for summary judgment of invalidity of the '380 and '552 patents received (cdod)
|
|
|
|
|
|
| 58 |
Filed: 11/13/2001, Entered: 11/13/2001, Terminated: 11/19/2001 |
Motion for Extension |
|
MOTION by Teva Pharmaceuticals, Smithkline Beecham, Glaxosmithkline PLC, Smithkline Beecham, Glaxosmithkline PLC to Extend Time to file certain objections and pleadings (cdod)
|
|
|
|
|
|
| 57 |
Filed: 11/5/2001, Entered: 11/6/2001 |
Memorandum in Support |
|
Both Cases MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in support of [56-1] cross motion for Partial Summary Judgment received (cdod) Modified on 11/06/2001
|
|
|
|
|
|
| 56 |
Filed: 11/5/2001, Entered: 11/6/2001 |
Motion for Summary Judgment |
|
Both Cases CROSS MOTION by Smithkline Beecham, Glaxosmithkline PLC for Partial Summary Judgment (cdod) Modified on 11/06/2001
|
|
|
|
|
|
| 55 |
Filed: 10/31/2001, Entered: 11/6/2001 |
Memorandum in Support |
|
2:01cv677 MEMORANDUM in support of [54-1] motion by Teva Pharmaceuticals for Summary Judgment received (cdod) Modified on 11/06/2001
|
|
|
|
|
|
| 54 |
Filed: 10/31/2001, Entered: 11/6/2001, Terminated: 2/25/2002 |
Motion for Summary Judgment |
|
2:01cv677 MOTION by Teva Pharmaceuticals for Summary Judgment (cdod) Modified on 11/06/2001
|
|
|
|
|
|
| 53 |
Filed: 10/31/2001, Entered: 10/31/2001 |
Order |
|
Rule 16(b) Scheduling Order: Setting Jury Trial at 10:00 am on 5/20/02 at Norfolk. Proposed voir dire and typewritten jury instructions, with authorities in support thereof, and proposed findings of fact and conclusions of law shall be delivered to the Clerk on or before May 13, 2002. Expert witnesses to be identified by 01/22/02; disclosure outlined in Rule 26 (a)(2)(B) by 02/22/02; response to such disclosure by 03/22/02; rebuttal by 04/08/02; discovery by plaintiff(s) on or before 04/08/02 and defendant(s) on or before 04/08/02; discovery/deposition in lieu of witness at trial concluded by 04/15/02; pretrial disclosures to be delivered to all counsel and unrepresented parties on or before 04/19/02; objections delivered by 04/24/02; an attorney's conference is set for 04/19/02 at 2:00 pm; a final pretrial conference shall be conducted on 04/26/02 at 11:00 am; Pursuant to the provisions of Rule 42(a) of the Federal Rules of Civil Procedure, it is ORDERED that this case be consolidated with 2:01cv677 for the purpose of trial. Counsel shall supply sufficient copies of all papers for each file. At this Rule 16(b) conference, counsel for plaintiff, Conrad Shumadine, represented that he accepts service on behalf of counterdefendent, Biochemie GmgH. The Court notes the pending motion for summary judgment of Teva Pharmaceuticals USA, Inc., filed 10/15/01. A hearing on this motion is scheduled on 12/14/01 at 10:30 am.; entered 10/29/01 filed 10/31/01 ( signed by Magistrate Judge Tommy E. Miller ) Copies Mailed: 10/31/01 (cdod) Modified on 10/31/2001
|
|
|
|
|
|
| -- |
Filed: 10/31/2001, Entered: 11/1/2001 |
Set/Clear Flags |
|
Consolidated Lead Case (cdod)
|
|
|
|
|
|
| -- |
Filed: 10/29/2001, Entered: 10/31/2001 |
Discovery Hearing |
|
16(b) Conference held (cdod)
|
|
|
|
|
|
| 52 |
Filed: 10/26/2001, Entered: 10/29/2001 |
Answer to Counterclaim |
|
ANSWER by Geneva Pharmaceuticals to [48-1] counter claim by Smithkline Beecham, Glaxosmithkline PLC (jcow)
|
|
|
|
|
|
| 51 |
Filed: 10/24/2001, Entered: 10/24/2001 |
Transcript |
|
TRANSCRIPT for dates of 10/17/01 Hearing on Motions for Summary Judgment OCR Horace P. Weiss (cdod)
|
|
|
|
|
|
| -- |
Filed: 10/18/2001, Entered: 10/18/2001 |
Order |
|
So Ordered: granting [37-1] motion by Smithkline Beecham, Glaxosmithkline PLC for Walter Wayne Brown for admission pro hac vice Filing Fee Paid $ 25.00 Receipt # 31253 entered and filed 10/18/01 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 10/18/01 (cdod)
|
|
|
|
|
|
| 50 |
Filed: 10/17/2001, Entered: 10/19/2001 |
Minutes-Miscellaneous |
|
Minute entry: COURT PROCEEDINGS: HCM, Jr, j; Horace Weiss, Contract Rptr. (Zahn-Hall-Zahn); Dimitrois T. Drivas, Conrad Shumadine & Leslie Morioka app. on behalf of ptf. Donald R. Dunner, Richard L. Rainey & Stephen Noona app. on behalf of dfts. (Alan Albert, cnsl. for ptf. Teva in Case No. 2:01cv392, present.) Came on for hrg. on following motions which were argued. Ptf's (#16) motion for summary judgment; dfts.' (#26) motion for partial summary judgment that the patents in suit are not invalid for double patenting; ptf's. (#40) second motion for summary judgment. Court suggested to cnsl. that an independent expert be appointed to advise court re terminology, etc. Cnsl. to send letter to court regarding this procedure with names of 3 experts agreed upon by cnsl. All motions taken under advisement. Court directed cnsl. to see Calendar Clerk to set trial date & Rule 16(b) conference date & include cnsl. in Case No. 2:01cv677 Teva Pharmaceuticals USA, Inc. v. Glaxosmithkline PLC as Teva has filed motion for consolidation of these cases. Alan Albert, cnsl. for Teva, present in courtroom & will participate in scheduling. Court's comments & findings read into record. Court kept file. (danc)
|
|
|
|
|
|
| -- |
Filed: 10/17/2001, Entered: 10/19/2001 |
Motion Hearing |
|
Motion hearing held re: [16-1] motion by Geneva for Summary Judgment by Geneva, [26-1] motion by Smithkline Beecham, Glaxosmithkline PLC for partial Summary Judgment by Smithkline Beecham, Glaxosmithkline PLC, [40-1] motion by Geneva for Summary Judgment by Geneva (danc)
|
|
|
|
|
|
| -- |
Filed: 10/12/2001, Entered: 10/12/2001 |
Summons Issued |
|
SUMMONS(ES) issued for Novartis AG, Biochemie GMBH with mag. notice, other notices, financial disclosures given to counsel for counterclaimant (cdod)
|
|
|
|
|
|
| 49 |
Filed: 10/9/2001, Entered: 10/10/2001 |
Reply to Response to Motion |
|
REPLY by Geneva to response to [40-1] motion by Geneva for Summary Judgment received (cdod)
|
|
|
|
|
|
| 48 |
Filed: 10/9/2001, Entered: 10/10/2001 |
Counterclaim |
|
COUNTERCLAIM by defendant Glaxosmithkline PLC, defendant Smithkline Beecham against plaintiff Geneva, Novartis AG, Biochemie GMBH (cdod)
|
|
|
|
|
|
| 48 |
Filed: 10/9/2001, Entered: 10/10/2001 |
Answer to Amended Complaint |
|
ANSWER by Glaxosmithkline PLC, Smithkline Beecham (Attorney ) to amended complaint; jury demand (cdod)
|
|
|
|
|
|
| -- |
Filed: 10/4/2001, Entered: 10/4/2001 |
Order |
|
So Ordered: granting [46-1] motion by Smithkline Beecham, Glaxosmithkline PLC for Donald Robert Dunner for admission pro hac vice Filing Fee Paid $ 25.00 Receipt #31524 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 10/04/01 (cdod)
|
|
|
|
|
|
| 47 |
Filed: 10/2/2001, Entered: 10/3/2001 |
Memorandum in Opposition |
|
MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in opposition to [40-1] motion by Geneva for Summary Judgment received (cdod)
|
|
|
|
|
|
| 46 |
Filed: 10/1/2001, Entered: 10/1/2001, Terminated: 10/4/2001 |
Motion for Pro Hac Vice |
|
MOTION by Smithkline Beecham, Glaxosmithkline PLC for Donald Robert Dunner for admission pro hac vice Filing Fee Paid $ 25.00 (cdod)
|
|
|
|
|
|
| 45 |
Filed: 9/24/2001, Entered: 9/24/2001 |
Order |
|
ORDER denying [31-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Dismiss, denying [31-2] motion by Smithkline Beecham, Glaxosmithkline to Change Venue; entered and filed 09/24/01 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 09/24/01 [EOD Date: 9/24/01] (cdod)
|
|
|
|
|
|
| 44 |
Filed: 9/21/2001, Entered: 9/21/2001 |
Memorandum in Opposition |
|
MEMORANDUM by Geneva in opposition to [31-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Dismiss , [31-2] motion to Change Venue; (copy of original document received in clerk's office 08/31/01 directed to be filed by chambers) received (cdod)
|
|
|
|
|
|
| 43 |
Filed: 9/20/2001, Entered: 9/20/2001 |
Order |
|
Agreed ORDER that Glazosmithkline shall have through 10/02/01 to file its opposition brief to Geneva's second motion for summary judgment set Respond Deadline 10/2/01 , and Geneva shall have through 10/09/01 to file its' reply brief in support of Geneva's second motion for summary judgment; set Brief deadline to 10/9/01 agreed, entered and filed 09/20/01 ( signed by Judge Henry C. Morgan Jr. ) Mailed: 09/20/01 [EOD Date: 9/20/01] (cdod)
|
|
|
|
|
|
| 42 |
Filed: 9/20/2001, Entered: 9/20/2001 |
Order |
|
Agreed ORDER that defendant Glaxosmithkline's Motion to Dismiss the Amended Complaint shall be referred to the Court for decision on the papers without oral argument and that Glaxosmithkline's responsive pleadings to the amended complaint, if any, shall be filed within 10 days after the entry of this court's order ruling on the Motion to Dismiss the amended complaint; agreed and entered 09/18/01 and filed 09/20/01 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 09/20/01 [EOD Date: 9/20/01] (cdod)
|
|
|
|
|
|
| 41 |
Filed: 9/14/2001, Entered: 9/17/2001 |
Memorandum in Support |
|
MEMORANDUM by Geneva in support of [40-1] second motion by Geneva for Summary Judgment received (cdod)
|
|
|
|
|
|
| 40 |
Filed: 9/14/2001, Entered: 9/17/2001 |
Motion for Summary Judgment |
|
Second MOTION by Geneva for Summary Judgment (cdod)
|
|
|
|
|
|
| 39 |
Filed: 9/12/2001, Entered: 9/13/2001 |
Reply to Response to Motion |
|
REPLY by Glaxosmithkline PLC, Smithkline Beecham to response to [26-1] motion by Smithkline Beecham, Glaxosmithkline PLC for partial Summary Judgment received (cdod)
|
|
|
|
|
|
| 38 |
Filed: 9/6/2001, Entered: 9/7/2001 |
Notice of Hearing. |
|
NOTICE of Hearing: on Wednesday, October 17, 2001 at 11:00 am on the motions for summary judgment (cdod)
|
|
|
|
|
|
| 37 |
Filed: 9/6/2001, Entered: 9/6/2001, Terminated: 10/18/2001 |
Motion for Pro Hac Vice |
|
MOTION by Smithkline Beecham, Glaxosmithkline PLC for Walter Wayne Brown for admission pro hac vice Filing Fee Paid $ 25.00 Receipt # 31253 (cdod)
|
|
|
|
|
|
| -- |
Filed: 9/5/2001, Entered: 9/5/2001 |
Motion Hearing |
|
Motion hearing re: [26-1] motion by Smithkline Beecham, Glaxosmithkline PLC for partial Summary Judgment set at 11:00 10/17/01, [16-1] motion by Geneva for Summary Judgment set at 11:00 10/17/01 (cdod)
|
|
|
|
|
|
| 36 |
Filed: 8/31/2001, Entered: 9/4/2001 |
Affidavit |
|
DECLARATION of Louis S. Silvestri (cdod)
|
|
|
|
|
|
| 35 |
Filed: 8/31/2001, Entered: 9/4/2001 |
Affidavit |
|
DECLARATION (Second) of Leslie Morioka (cdod)
|
|
|
|
|
|
| 34 |
Filed: 8/31/2001, Entered: 9/4/2001 |
Memorandum in Opposition |
|
MEMORANDUM by Geneva in opposition to [26-1] motion by Smithkline Beecham, Glaxosmithkline PLC for partial Summary Judgment received (cdod)
|
|
|
|
|
|
| 33 |
Filed: 8/31/2001, Entered: 9/4/2001 |
Reply to Response to Motion |
|
REPLY by Geneva to response to [16-1] motion by Geneva for Summary Judgment received (cdod)
|
|
|
|
|
|
| 32 |
Filed: 8/28/2001, Entered: 8/28/2001 |
Order |
|
ORDER denying [10-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Dismiss pursuant to Rule 12(b)(1) for lack of subject matter jurisdiction; entered 08/27/01 and filed 08/28/01 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 08/28/01 [EOD Date: 8/28/01] (cdod)
|
|
|
|
|
|
| 31 |
Filed: 8/24/2001, Entered: 8/28/2001, Terminated: 9/24/2001 |
Motion to Dismiss |
|
MOTION with Memorandum in Support by Smithkline Beecham, Glaxosmithkline PLC to Dismiss , by Smithkline Beecham, Glaxosmithkline to Change Venue (cdod)
|
|
|
|
|
|
| 30 |
Filed: 8/24/2001, Entered: 8/24/2001 |
Order |
|
Agreed ORDER Extending Time for plaintiff to file its reply brief in support of its motion for summary judgment to 08/31/01 and the time for the defendants to file their reply brief in support of their motion for partial summary judgment is extended to 09/11/01; agree, entered and filed 08/24/01 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 08/24/01 [EOD Date: 8/24/01] (cdod)
|
|
|
|
|
|
| 29 |
Filed: 8/20/2001, Entered: 8/21/2001 |
Amended Complaint |
|
AMENDED COMPLAINT by Geneva Pharmaceuticals, Inc. (cdod)
|
|
|
|
|
|
| 28 |
Filed: 8/17/2001, Entered: 8/20/2001 |
Memorandum in Opposition |
|
MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in opposition to [16-1] motion by Geneva for Summary Judgment received (cdod)
|
|
|
|
|
|
| 27 |
Filed: 8/17/2001, Entered: 8/20/2001 |
Memorandum in Support |
|
MEMORANDUM by Glaxosmithkline PLC, Smithkline Beecham in support of [26-1] motion for partial Summary Judgment received (cdod)
|
|
|
|
|
|
| 26 |
Filed: 8/17/2001, Entered: 8/20/2001 |
Motion for Summary Judgment |
|
MOTION by Smithkline Beecham, Glaxosmithkline PLC for partial Summary Judgment that the patenets in suit are not invalid for double patenting (cdod)
|
|
|
|
|
|
| 25 |
Filed: 8/2/2001, Entered: 8/3/2001 |
Transcript |
|
TRANSCRIPT for dates of 07/31/01 Motion to Dismiss and Transfer Hearing (cdod)
|
|
|
|
|
|
| 24 |
Filed: 7/31/2001, Entered: 8/1/2001 |
Minutes-Miscellaneous |
|
Minute entry: HEARING PROCEEDINGS: HCM, Jr., j; Diane Gray, OCR; app. by Dimitrios Theodore Drivas, Conrad Shumadine, Leslie Morioka & Louis Sebastian Silvestri on behalf of ptf. and Ford F. Farabow, Jr., Liam O'Grady, Stephen Noona (& Stephen Venetianer, dfts.' in house cnsl) on behalf of dfts. Came on for hrg. on the following motions; argued. Dfts.' motion (#10) to dismiss purs. to Rule 12(b)(1) for lack of subject matter jurisdiction, or, in the alternative, to transfer venue purs. to 28 USC 1404(a); taken under advisement. Dfts.' motion (#20) to extend time; GRANTED. Dfts. reply to motion for summary judgment shall be filed by Aug. 17, 2001. Court's comments read into record. Court kept file. (danc)
|
|
|
|
|
|
| 23 |
Filed: 7/31/2001, Entered: 7/31/2001 |
Reply to Response to Motion |
|
REPLY by Glaxosmithkline PLC, Smithkline Beecham to response to [20-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Extend Time, received. (clerk)
|
|
|
|
|
|
| -- |
Filed: 7/31/2001, Entered: 8/1/2001 |
Motion Hearing |
|
Motion hearing held re: [20-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Extend Time by Smithkline Beecham, Glaxosmithkline PLC, [10-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Dismiss pursuant to Rule 12(b)(1) for lack of subject matter jurisdiction by Smithkline Beecham, Glaxosmithkline PLC (danc)
|
|
|
|
|
|
| 22 |
Filed: 7/30/2001, Entered: 7/30/2001, Terminated: 2/19/2002 |
Motion for Pro Hac Vice |
|
MOTION by Stephen E. Noona by Smithkline Beecham, Glaxosmithkline PLC for Ford Franklin Farabow for admission pro hac vice Filing Fee $ 25.00 (cdod)
|
|
|
|
|
|
| 21 |
Filed: 7/27/2001, Entered: 7/27/2001 |
Memorandum in Opposition |
|
MEMORANDUM by Geneva in opposition to [20-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Extend Time, received (mwin)
|
|
|
|
|
|
| 20 |
Filed: 7/24/2001, Entered: 7/25/2001, Terminated: 2/11/2002 |
Motion for Extension |
|
MOTION by Smithkline Beecham, Glaxosmithkline PLC to Extend Time (cdod)
|
|
|
|
|
|
| 19 |
Filed: 7/20/2001, Entered: 7/23/2001 |
Notice |
|
NOTICE by Smithkline Beecham, Glaxosmithkline PLC for Hearing on the Motion to Dismiss (cdod)
|
|
|
|
|
|
| -- |
Filed: 7/20/2001, Entered: 7/23/2001 |
Motion Hearing |
|
Motion hearing re: [10-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Dismiss pursuant to Rule 12(b)(1) for lack of subject matter jurisdiction set at 2:30 7/31/01 (cdod)
|
|
|
|
|
|
| 18 |
Filed: 7/19/2001, Entered: 7/20/2001 |
Affidavit |
|
DECLARATION of Richard E. Fichter in support of GlaxoSmithKline PLC and SmithKline Beacham Corp. to dismiss; to be attached to memeorandum that was previously filed on 07/18/01 as Exhibit D; memorandum was filed with a copy of this declaration (cdod)
|
|
|
|
|
|
| Save 25% on a pre-paid one year subscription. |
|
|
| 18 |
Filed: 7/18/2001, Entered: 7/19/2001 |
Reply to Response to Motion |
|
REPLY by Glaxosmithkline PLC, Smithkline Beecham to response to [10-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Dismiss pursuant to Rule 12(b)(1) for lack of subject matter jurisdiction received (cdod)
|
|
|
|
|
|
| 17 |
Filed: 7/13/2001, Entered: 7/16/2001 |
Memorandum in Support |
|
MEMORANDUM by Geneva in support of [16-1] motion for Summary Judgment received (cdod)
|
|
|
|
|
|
| 16 |
Filed: 7/13/2001, Entered: 7/16/2001 |
Motion for Summary Judgment |
|
MOTION by Geneva for Summary Judgment (cdod)
|
|
|
|
|
|
| 15 |
Filed: 7/13/2001, Entered: 7/16/2001 |
Affidavit |
|
DECLARATION of Louis S. Silvestri in support of Geneva Pharmaceuticals, Inc.'s Memorandum in Opposition to GlaxoSmithKline's Motion to Dismiss (cdod)
|
|
|
|
|
|
| 15 |
Filed: 7/13/2001, Entered: 7/16/2001 |
Memorandum in Opposition |
|
MEMORANDUM by Geneva in opposition to [10-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Dismiss pursuant to Rule 12(b)(1) for lack of subject matter jurisdiction received (cdod)
|
|
|
|
|
|
| -- |
Filed: 7/11/2001, Entered: 7/11/2001 |
Order |
|
So Ordered: Denying [14-1] motion by Smithkline Beecham, Glaxosmithkline PLC re: Walter Wayne Brown for admission pro hac vice, Filing Fee Paid $ 25.00 Receipt # 30413 as counsel is not admitted to any federal court, entered and filed 7/11/01 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 7/11/01 (jcow)
|
|
|
|
|
|
| -- |
Filed: 7/10/2001, Entered: 7/11/2001 |
Order |
|
So Ordered: granting [12-1] motion by Smithkline Beecham, Glaxosmithkline PLC re: Richard Lawrence Rainey for admission pro hac vice, Filing Fee Paid $ 25.00 Receipt # 30415, entered and filed 7/11/01, ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 7/11/01 (clerk)
|
|
|
|
|
|
| -- |
Filed: 7/10/2001, Entered: 7/11/2001 |
Order |
|
So Ordered: granting [13-1] motion by Smithkline Beecham, Glaxosmithkline PLC re: Kelly Ann Casey for admission pro hac vice, Filing Fee Paid $ 25.00 Receipt # 30414, entered and filed 7/10/01, ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 7/11/01 (clerk)
|
|
|
|
|
|
| 14 |
Filed: 7/9/2001, Entered: 7/10/2001 |
Motion for Pro Hac Vice |
|
MOTION by Smithkline Beecham, Glaxosmithkline PLC re: Walter Wayne Brown for admission pro hac vice, Filing Fee Paid $ 25.00 Receipt # 30413 (jcow)
|
|
|
|
|
|
| 13 |
Filed: 7/9/2001, Entered: 7/10/2001 |
Motion for Pro Hac Vice |
|
MOTION by Smithkline Beecham, Glaxosmithkline PLC re: Kelly Ann Casey for admission pro hac vice, Filing Fee Paid $ 25.00 Receipt # 30414 (jcow)
|
|
|
|
|
|
| 12 |
Filed: 7/9/2001, Entered: 7/10/2001 |
Motion for Pro Hac Vice |
|
MOTION by Smithkline Beecham, Glaxosmithkline PLC re: Richard Lawrence Rainey for admission pro hac vice, Filing Fee Paid $ 25.00 Receipt # 30415 (jcow)
|
|
|
|
|
|
| -- |
Filed: 7/3/2001, Entered: 7/5/2001 |
Order |
|
So Ordered: granting [9-1] motion by Geneva Louis Sebastian Silvestri for admission pro hac vice Filing Fee Paid $ 25.00 Receipt # 30281, entered and filed 7/3/01, ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 7/3/01 (ariv)
|
|
|
|
|
|
| -- |
Filed: 7/3/2001, Entered: 7/5/2001 |
Order |
|
So Ordered: granting [8-1] motion by Geneva Dimitrios Theodore Drivas for admission pro hac vice Filing Fee Paid $ 25.00 Receipt # 30280, entered and filed 7/3/01, ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 7/3/01 (ariv)
|
|
|
|
|
|
| -- |
Filed: 7/3/2001, Entered: 7/5/2001 |
Order |
|
So Ordered: granting [7-1] motion by Geneva Leslie Morioka for admission pro hac vice Filing Fee Paid $ 25.00 Receipt # 30279, entered and filed 7/3/01, ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 7/3/01 (ariv)
|
|
|
|
|
|
| 11 |
Filed: 7/2/2001, Entered: 7/3/2001 |
Affidavit |
|
AFFIDAVIT of Brian A. Lortie Re: [11-1] support memorandum by Smithkline Beecham, Glaxosmithkline PLC (ariv)
|
|
|
|
|
|
| 11 |
Filed: 7/2/2001, Entered: 7/3/2001 |
Memorandum in Support |
|
MEMORANDUM in support of [10-1] motion to Dismiss pursuant to Rule 12(b)(1) for lack of subject matter jurisdiction, [10-2] motion to Transfer Venue pursuant to 28 USC 1404(a) by Smithkline Beecham, Glaxosmithkline PLC, received. (ariv)
|
|
|
|
|
|
| 10 |
Filed: 7/2/2001, Entered: 7/3/2001, Terminated: 8/28/2001 |
Motion to Dismiss |
|
MOTION by Smithkline Beecham, Glaxosmithkline PLC to Dismiss pursuant to Rule 12(b)(1) for lack of subject matter jurisdiction , or, in the alternative, by Smithkline Beecham, Glaxosmithkline PLC to Transfer Venue pursuant to 28 USC 1404(a) (ariv)
|
|
|
|
|
|
| 9 |
Filed: 7/2/2001, Entered: 7/3/2001 |
Motion for Pro Hac Vice |
|
MOTION by Geneva Louis Sebastian Silvestri for admission pro hac vice Filing Fee Paid $ 25.00 Receipt # 30281 (ariv)
|
|
|
|
|
|
| 8 |
Filed: 7/2/2001, Entered: 7/3/2001 |
Motion for Pro Hac Vice |
|
MOTION by Geneva Dimitrios Theodore Drivas for admission pro hac vice Filing Fee Paid $ 25.00 Receipt # 30280 (ariv)
|
|
|
|
|
|
| 7 |
Filed: 7/2/2001, Entered: 7/3/2001 |
Motion for Pro Hac Vice |
|
MOTION by Geneva Leslie Morioka for admission pro hac vice Filing Fee Paid $ 25.00 Receipt # 30279 (ariv)
|
|
|
|
|
|
| -- |
Filed: 7/2/2001, Entered: 7/5/2001 |
Set/Reset Deadlines: |
|
Deadline updated; Response to Motion reset to 7/13/01 for [10-1] motion by Smithkline Beecham, Glaxosmithkline PLC to Dismiss pursuant to Rule 12(b)(1) for lack of subject matter jurisdiction, for [10-2] motion by Smithkline Beecham, Glaxosmithkline PLC to Transfer Venue pursuant to 28 USC 1404(a) (ariv)
|
|
|
|
|
|
| 6 |
Filed: 6/25/2001, Entered: 6/25/2001 |
Order |
|
AGREED ORDER that defendants shall have to and including 07/02/01 in which to answer or otherwise plead to the Complaint filed by the plaintiff reset Answer deadline to 7/2/01 for Smithkline Beecham, for Glaxosmithkline PLC agreed, entered and filed 06/25/01 ( signed by Judge Henry C. Morgan Jr. ) Copies Mailed: 06/25/01 [EOD Date: 6/25/01] (cdod)
|
|
|
|
|
|
| 5 |
Filed: 6/14/2001, Entered: 6/14/2001 |
Financial Disclosure Statement |
|
Financial Interest Disclosure Statement (Local Rule 7.1) by Geneva Pharmaceuticals, Inc. (clerk)
|
|
|
|
|
|
| 4 |
Filed: 6/14/2001, Entered: 6/14/2001 |
Summons Returned Executed |
|
SUMMONS Returned Executed as to Smithkline Beecham Corporation on 6/4/01; Answer due on 6/25/01 for Smithkline Beecham Corporation. (clerk)
|
|
|
|
|
|
| 3 |
Filed: 6/14/2001, Entered: 6/14/2001 |
Summons Returned Executed |
|
SUMMONS Returned Executed as to Glaxosmithkline PLC on 6/1/01; Answer due on 6/21/01 for Glaxosmithkline PLC (clerk)
|
|
|
|
|
|
| -- |
Filed: 6/5/2001, Entered: 6/5/2001 |
Case Assigned/Reassigned |
|
CASE assigned to Judge Henry C. Morgan Jr. (ariv)
|
|
|
|
|
|
| -- |
Filed: 6/4/2001, Entered: 6/4/2001 |
Miscellaneous Document |
|
Magistrate's consent form mailed to plaintiff's counsel (jcow)
|
|
|
|
|
|
| 2 |
Filed: 5/31/2001, Entered: 6/4/2001 |
Summons Returned Executed |
|
Summons returned unexecuted as to Glaxosmithkline PLC (jcow) Modified on 06/11/2001
|
|
|
|
|
|
| 1 |
Filed: 5/31/2001, Entered: 6/4/2001 |
Complaint |
|
COMPLAINT, Filing Fee $ 150.00 Receipt # 146224; jury demand, received 6/1/01; filed in Alexandria Division 5/31/01 (jcow) Modified on 06/05/2001
|
|
|
|
|
|
| -- |
Filed: 5/31/2001, Entered: 6/4/2001 |
Docket Annotation |
|
Summonses issued for both defendants and provided to counsel for plaintiff on 5/31/01 by Alexandria Division (jcow) Modified on 06/05/2001
|
|
|
|
|
|
| -- |
Filed: 5/31/2001, Entered: 6/4/2001 |
Docket Annotation |
|
Summons issued by Alexandria Division for Glaxosmithkline on 5/31/01 (jcow) Modified on 06/21/2001
|
|
|
|
|
|
| -- |
Filed: 5/31/2001, Entered: 6/4/2001 |
Set/Clear Flags |
|
Jury Trial Flag (jcow) Modified on 06/05/2001
|
|
|
|
Update
Alerts
